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ABSTRACT 
 
The overall goal of my thesis study is to use a metabolic engineering approach for 
developing optimal yeast cell factories capable of efficiently fermenting various sugars abundant 
in renewable biomass.  The research has broad applications for sustainable biological production 
of value-added fuels and chemicals.  Initially, a systematic approach based on global reaction 
stoichiometry was applied to select gene knockout targets in Saccharomyces cerevisiae for 
enhancing bioethanol production from glucose with minimal impact on biomass yield.  Due to 
the limited scope of stoichiometric models, genetic screening was combined with the model-
based technique, and this led to identification of three knockout mutants (∆cox9, ∆qcr6, and 
∆qcr9) with superlative characteristics for enhancing fermentation of glucose and other hexoses 
(sucrose, fructose, and mannose).  Although deletion of a respiratory enzyme subunit (Cox9) 
identified by the model-based approach severely inhibited galactose metabolism, the deletion 
was a necessary intermediate step for the respiration-deficient yeast to reach efficient galactose 
fermentation rapidly through serial subculture in galactose media.  The combination of 
systematic and combinatorial methods led to an optimal phenotype on galactose that could not 
have been achieved by either method independently and demonstrates a promising approach for 
directing adaptive evolution toward fermentative metabolism.  To understand the genetic basis of 
the improved phenotype, genome sequencing was conducted and used to identify a loss of 
function mutation in a repressor of galactose metabolic genes (Gal80p); this mutation was found 
to act synergistically with inhibition of respiration for efficient galactose fermentation by S. 
cerevisiae.  A similar ‘fermentative evolution’ approach, involving deletion of COX9 and serial 
subculture in xylose minimal media, was applied to improve ethanol fermentation by a xylose-
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fermenting yeast strain previously developed in our group (SR8).  Genome sequencing and a 
yeast mating experiment led to identification of a frameshift mutation in a transcriptional 
regulatory complex subunit (Spt3p) for improving xylose fermentation in engineered respiration-
deficient yeast.  Ethanol production was significantly improved in the xylose-evolved mutant, 
but excessive xylitol production demonstrated a redox imbalance problem due to NAD
+
 shortage 
without respiration.  Two separate strategies were effective for alleviating the redox imbalance 
problem and further improving ethanol fermentation from xylose in the respiration-deficient 
evolved strain: i) expression of a NADH-consuming acetate reduction pathway, or ii) expression 
of a mutant NADH-preferring xylose reductase.   
In summary, this metabolic engineering study utilizes model-based and evolutionary 
tools for development of yeast cell factories that can rapidly ferment sugars abundant in non-
food plant biomass.  Furthermore, we demonstrate a novel strategy for redirecting sugar 
metabolism toward the fermentation pathway by systematic deletion of a respiration-related gene 
and adaptive evolution in selective conditions.  The work in this study advances knowledge of 
limiting factors for sugar fermentation under anaerobic conditions and describes metabolic 
engineering strategies for overcoming these limitations.  Efficient sugar-fermenting strains that 
can function in the absence of oxygen (i.e. without respiration), such as the ones developed in 
this study, are desirable because they prohibit respiratory utilization of sugars and oxidative 
metabolism of alcohol or other fermentation products, both of which can reduce product yield.  
Thus, engineering and characterization of respiration-deficient yeast strains provides valuable 
knowledge and understanding that may have applications for industrial fermentation processes.  
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CHAPTER I       INTRODUCTION TO METABOLIC ENGINEERING FOR 
PRODUCTION OF FUELS AND CHEMICALS 
 
 
 
 
 
 
 
 
 
 
 
 
 
The content of this chapter will be submitted to Applied Microbiology and Biotechnology as a 
review article.  I am the first author of the paper and Yong-Su Jin is the co-author.   
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1.1  Needs and motivation: biological production of fuels and chemicals 
Over the last few decades, advances in metabolic engineering and synthetic biology have 
contributed to improvement in the cellular properties of a variety of microorganisms for 
biosynthesis of value-added products.  Furthermore, consumers and industries are increasingly 
aware of environmental issues and unsustainability surrounding the traditional chemical 
synthesis of fuels, bulk chemicals, and other products from petroleum-derived hydrocarbons 
(Saxena et al., 2009).  For the development of a sustainable industrial society with controlled 
greenhouse gas emissions, a shift from traditional petroleum resources to renewable biomass 
feedstocks is generally viewed as an important and positive step.  Some visionaries expect that 
the growing ‘carbohydrate economy’ will one day replace much of the old ‘hydrocarbon 
economy’ that has prevailed since the Industrial Revolution (Ragauskas et al., 2006).  In this 
context, global interest is being directed towards research and commercialization of more bio-
based renewable products to address current and future societal needs.  The rise of the 
biorefinery concept provides vast opportunity for scientists and engineers to apply an ever-
growing set of biotechnology tools in the context of metabolic engineering for developing 
microbial cell factories that can produce the next generation of bioproducts. 
Recent advances in microbial production of bioethanol and other biofuels offer a 
prominent example of the paradigm shift towards biological processes utilizing renewable raw 
materials.  The Deepwater Horizon oil spill in the Gulf of Mexico, political tensions in the 
Middle East, and unstable oil prices have directed particular attention at the need for sustainable, 
efficient, cost-effective, and cleaner-burning domestic energy sources.  In general, the overall 
life-cycle analysis for biofuels showed an improvement over traditional fossil fuel resources as 
the greenhouse gas emitted during combustion is mitigated by the inorganic carbon fixed from 
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atmospheric carbon dioxide during growth of the biomass feedstock (Davis et al., 2009).  
Furthermore, biofuels such as ethanol are less toxic, biodegradable, and generate fewer 
pollutants than petroleum fuels (John et al., 2011).  However, the status quo of using food crops 
for biofuel conversion is a limited solution and cannot satisfy the full demand for renewable 
fuels.  Corn and sugarcane are the most widely utilized raw materials for biofuel synthesis 
because of well-established farming practices and simple, cheap processes for release of 
fermentable sugars.  Despite the economic and technological feasibility of first generation 
bioethanol from these food crops, its production is controversial and greatly limited due to 
unavailability of more arable land for growing the feedstocks and concerns about food scarcity 
and increasing prices of food commodities (John et al., 2011).   
For a sustainable future, bioethanol and other biofuels should be generated from any of a 
wide variety of alternative, renewable non-food organic sources.  For example, one plausible 
alternative that has been a focus of extensive research is use of terrestrial non-food biomass, such 
as agricultural residues, wood waste, or energy grasses, as a raw material for biofuel production 
(Himmel et al., 2007).  These lignocellulosic biomass sources are advantageous because of low 
cost, minimal land use change, and avoidance of the competition between food and fuel.  
However, current chemical and biological technologies have yet to overcome the significant 
obstacles to releasing sugars from recalcitrant lignocellulose and efficiently converting pentoses 
(e.g. xylose) to target fuel molecules with high yields and productivities (Jones and Mayfield, 
2012).  Marine plant biomass is another promising feedstock that can be used for producing fuels 
and chemicals and has some advantages over terrestrial biomass.  For example, macroalgae does 
not require arable land, can grow in salt water or municipal waste water, synthesizes biomass 
very rapidly, and can be depolymerized easily due to lack of hemicellulose and lignin (Wei et al., 
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2012).  Galactose is a major sugar obtained from hydrolysis of some marine macroalgae, but 
industrial microorganisms do not utilize this sugar efficiently due to tight regulation of the 
galactose metabolic pathway, called the Leloir pathway (Bro et al., 2005; Holden et al., 2003).  
In light of these technological challenges, engineered microbial strains for converting renewable 
biomass to biofuels should possess at least two specific characteristics: (i) capable of efficiently 
metabolizing various sugars abundant in biomass sources, and (ii) rapid (productivity) and 
efficient (yield) production of fuel or chemical molecules.  To overcome the deficiencies of 
naturally existing microorganisms, concepts and methodologies from metabolic engineering have 
been employed to develop optimal strains with these characteristics. 
 
1.2 Overview of metabolic engineering: basic concepts and methodologies 
Before the advent of techniques for DNA recombination, microbial strain improvement 
relied heavily on the use of mutagens, such as ultraviolet (UV) irradiation or chemical agents, 
and clever selection techniques to isolate improved strains for overproduction of some target 
molecules (Thoma, 1971).  While this approach was not unsuccessful, the mutant strains were 
poorly understood and their development depended solely on random, time-consuming processes 
with little science or engineering involved.  In the 1970s, the development of recombinant DNA 
technology introduced a new dimension to strain improvement by providing the skills for 
modification of specific enzymatic reactions in a cell’s metabolic pathways.  The control of 
pathway modification is a key element that distinguishes metabolic engineering from previous 
strain improvement approaches.  Thus, metabolic engineering has been defined as “the directed 
improvement of product formation or cellular properties through the modification of specific 
biochemical reaction(s) or the introduction of new one(s) with the use of recombinant DNA 
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technology” (Stephanopoulos et al., 1998).  This multidisciplinary field draws from the 
knowledge base and skill set provided by biochemistry, genetics, molecular biology, cellular 
physiology, chemical engineering, and more.   
Since metabolic engineering is a strategic and directed approach for strain improvement, 
it requires a solid understanding of the system being studied and not just individual reactions or 
pathways (Ostergaard et al., 2000c).  A holistic approach is important for studying cellular 
metabolism because there are often some unexpected or uncharacterized interactions between 
pathways or reactions in a cell.  Thus, one should make some distinction between genetic 
engineering, with its focus on an individual enzyme or pathway, and metabolic engineering, with 
its focus on integrated metabolic pathways and regulatory networks.  Some pioneers of metabolic 
engineering suggest that the field preceded and paved the way for systems biology by creating a 
definite need for an overall or system-wide view of metabolism (Woolston et al., 2013). 
Two important and interrelated components make up the foundation of metabolic 
engineering: a careful analysis of the metabolic system and precise synthesis of the recombinant 
strain (Ostergaard et al., 2000c).  Initially, when techniques for DNA recombination were still 
young, more attention was focused on the synthetic side of the field, which includes the 
expression of new genes in a host organism, deletion or amplification of existing genes, 
modulation of enzymatic activity, or transcriptional deregulation (Stephanopoulos et al., 1998).  
Generally, the synthesis step is fairly straightforward in cases where the gene to be expressed is 
available and the host organism is genetically well-characterized.   However, it is the analysis 
step that is often limiting in metabolic engineering studies (Ostergaard et al., 2000c).  It is 
important to realize that the analytical step distinguishes metabolic engineering, a field with a 
strong engineering or problem-solving component, from an applied biology.  There are at least 
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three major tasks from a network analysis perspective, and each of these tasks presents some 
significant challenges.  First, analysis involves a detailed evaluation of cellular physiology. 
Systems biology tools including metabolic flux determination and metabolite profiling as well as 
measurement of gene expression, cell growth, or metabolite exchange rate may be helpful for 
characterizing cellular function in a microbial strain (Stephanopoulos and Sinskey, 1993).  The 
key question here is: how can we identify the most important parameters for defining the 
physiological state of the cell?  Second, the physiological (or phenotypic) information should be 
used to elucidate control points in the network and thus identify specific genetic, enzymatic, or 
regulatory modifications towards the accomplishment of the objective.  A set of genetic 
manipulations may be chosen and ranked in ascending order of difficulty (Stephanopoulos, 
2002).  Third, after synthesis of the recombinant strain, the actual impact of the genetic and 
enzymatic modifications should be assessed for designing further genetic manipulations 
(Stephanopoulos et al., 1998).  We emphasize here that analysis and synthesis are not two 
separate or linear steps, but actually these two steps are closely related and often proceed as a 
cycle through several rounds of engineering until an optimal strain emerges (Ostergaard et al., 
2000c).   
Over the last two decades, metabolic engineering has grown quickly and found a wide 
variety of applications, such as increasing the range of substrate utilization, improving product 
yield or production rate, diversifying the range of products synthesized, reducing byproduct 
accumulation, or improvement of other cellular properties (Stephanopoulos, 1999).  Some 
interesting properties that have been conferred to microorganisms include the ability to thrive in 
stressful environments (Hong et al., 2010) or balancing the redox potential within the cell 
(Berrı́os-Rivera et al., 2002).  Metabolic engineering has also found applications for 
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biodegradation of harmful pollutants in the environment (Haro and de Lorenzo, 2001), 
production of chiral compounds for pharmaceutical synthesis (Lee et al., 2009), and production 
of biopolymer molecules with desirable structures and properties (Aldor and Keasling, 2003).  In 
general, metabolic engineering has a distinct focus on designing microbial factories for industrial 
applications, such as large-scale production of fuels, chemicals, and pharmaceuticals, in an 
efficient and economical way.  A cost-effective process for industrial use cannot be realized until 
the three factors of titer, productivity, and yield have all been optimized (Woolston et al., 2013).  
Therefore, metabolic engineers are concerned with much more than just piecing genes together 
to construct a new functioning metabolic pathway.   In just a few months, synthetic biologists 
may be able to construct a new working pathway for synthesis of a desired product on the order 
of milligrams, but it can take years for metabolic engineers to optimize the strain so that it can 
support an efficient large-scale process. This distinguished metabolic engineering from the 
overlapping field of synthetic biology (Woolston et al., 2013).  
The identification of novel gene targets impacting the production phenotype of 
recombinant strains is a limiting step of metabolic engineering and a critical aspect of industrial 
strain construction (Stephanopoulos et al., 1998).  Two general approaches have been described 
to locate interesting gene targets for metabolic engineering: systematic approaches (Fig. 1.1) and 
combinatorial approaches (Fig. 1.2) (Alper et al., 2005b).  The following sections will describe 
these general approaches and then review some applications in the context of engineering 
Saccharomyces cerevisiae for production of fuels and chemicals.   
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1.3 Systematic approaches for metabolic engineering 
Many early metabolic engineering studies relied primarily on ad hoc target selection for 
strain improvement (Stephanopoulos et al., 1998).  This means that some logical genetic changes 
were identified for increasing flux through a particular target pathway by reason and visual 
inspection of a metabolic network.  The ad hoc pathway manipulation approach is quite limited 
because of unknown interactions in the system and lack of any rigorous analysis or justification. 
The growth of metabolic engineering has been fueled by development of more comprehensive 
tools for analysis. 
 
1.3.1  Stoichiometric modeling 
The availability of genome sequences for many organisms has facilitated the 
development of metabolic models for cellular metabolism that permit systematic approaches of 
gene target identification (Alper, 2006).  These models enable the mathematical description of 
metabolic function in terms of distribution of metabolic flux, which is a fundamental indicator of 
cellular physiology and the most important factor for metabolic engineering of a cell 
(Stephanopoulos et al., 1998).  Over the last two decades, a particular emphasis has been placed 
on using stoichiometric models for predicting metabolic flux distribution and identifying gene 
targets in a systematic way.  Stoichiometric models are advantageous because they only require 
information about stoichiometry and reversibility of enzymatic reactions without the need for 
any of the difficult-to-measure kinetic parameters that are required for more theoretical 
approaches (Orth et al., 2010; Varma and Palsson, 1994).  The application of stoichiometric 
models depends on a mass balance around each of the internal metabolites in a network and 
results in a system of differential equations representing the dynamic mass balance (Llaneras and 
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Picó, 2008; Papoutsakis, 1984).  Subsequently, a steady-state assumption can be applied, which 
is based on the idea that changes in intracellular metabolism are very fast compared to 
extracellular changes in resultant phenotype (Lee et al., 2006).  By assuming a quasi steady-state 
condition for internal metabolites, the sum of all fluxes involving formation, degradation and 
transport of a metabolite must equal zero.  This basic assumption is critical because it allows the 
dynamic mass balance equation to be simplified into a system of linear equations.  In matrix 
form, the steady-state flux balance equation can be written as: 
S • ν = 0          (Equation 1) 
where S is the stoichiometric matrix and ν is a vector of reaction fluxes.  Additional 
thermodynamic information should also be considered to account for all irreversible reactions i 
in the flux vector ν: 
νi ≥ 0               (Equation 2) 
In most cases, Equation 1 describes an underdetermined system with infinite solutions 
because there are often many more reaction fluxes (unknowns) than metabolites (equations) in a 
network (Schilling et al., 1999).  Thus, Equation 1 defines what a metabolic network cannot do 
and describes a solution space where every possible flux distibution ν lies, but it cannot predict a 
single flux solution.  This is quite logical as cells can show different phenotypes depending on 
carbon source, oxygen availability, and other environmental conditions (Llaneras and Picó, 
2008).  In this review, we will focus on two fundamental stoichiometric model-based approaches 
to solve Equation 1 with the constraints in Equation 2 in a meaningful way: flux balance analysis 
and metabolic pathway analysis.  These tools are related in that they are both based on the 
stoichiometric matrix and a steady-state assumption, but they also have clear differences in flux 
calculation and applications for metabolic engineering.   
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1.3.2  Flux balance analysis 
Flux balance analysis (FBA) has been defined as “a mathematical approach for analyzing 
the flow of metabolites through a metabolic network” (Orth et al., 2010).  This method provides 
an explicit prediction of metabolic behavior based on some defined reaction constraints and an 
objective function.  Linear programming can be applied to solve for the flux balances (Equation 
1) together with the thermodynamic constraints (Equation 2) and other reaction constraints of the 
metabolic network.  Therefore, the in silico flux distribution, which represents the strain’s 
predicted phenotype under the defined conditions, is highly dependent on a suitable choice for 
objective function.  Maximization of biomass has been demonstrated as a useful objective 
function in many studies with microorganisms, such as Escherichia coli or Saccharomyces 
cerevisiae (Edwards et al., 2001; Famili et al., 2003).  Biomass production is considered by 
including a biomass reaction in the stoichiometric matrix, which converts precursor metabolites 
to biomass at appropriate stoichiometric ratios based on biomass composition (Orth et al., 2010).  
For a S. cerevisae genome-scale model, the maximization of biomass objective led to in silico 
predictions consistent with experimental results in ~70-80% of the cases considered (Famili et 
al., 2003).  While this objective function has been used in a vast majority of FBA applications, it 
should be noted that others have also been effective, such as minimizing ATP generation, 
minimizing nutrient consumption, or maximizing synthesis of a specific metabolite (Llaneras and 
Picó, 2008).  Some significant limitations of the FBA approach include its assumption of a 
cellular objective and general lack of kinetic or regulatory information. 
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1.3.3  Metabolic pathway analysis 
In contrast to the above, metabolic pathway analysis provides no explicit prediction of 
phenotype but rather calculates all the possible flux solutions in a metabolic network without 
need for fixed flux rates or an objective function.  This gives a complete understanding of an 
organism’s metabolic capabilities (Trinh et al., 2009).  Two closely related metabolic pathway 
analysis approaches are elementary flux mode (EFM) analysis and extreme pathway (EP) 
analysis; here we will focus on the former.  An EFM has been defined as “a minimal set of 
enzymes that can operate at steady state with all irreversible reactions proceeding in the 
appropriate direction” (Schuster and Hilgetag, 1994; Schuster et al., 2002).   For a given 
network, a set of EFMs define and describe all the independent metabolic routes that are both 
stoichiometrically and thermodynamically feasible.  Thus, EFM analysis is a powerful 
mathematical tool for decomposing a complex metabolic network of many interconnected 
reactions into unique, organized pathways that support steady state metabolism. The modes are 
calculated by solving Equation 1 with Equation 2 and a non-decomposability constraint, which 
ensures a finite number of solutions and that each solution is unique (Trinh et al., 2009).  EFM 
analysis can provide determination of the most efficient physiological state of a cell, analysis of 
metabolic network properties such as robustness and regulation, and a tool for rational design of 
the host strain’s metabolism (Llaneras and Picó, 2008; Pfeiffer et al., 1999; Schuster et al., 
2000).  The major limitation of this approach is computationally expensive calculation, which 
grows exponentially with the size of the metabolic network. 
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1.3.4  Rational strain design by EFM analysis 
  The calculation of all unique and feasible pathways in a metabolic network permits the 
rational design of strains for accomplishing a specific metabolic objective.  By careful in silico 
manipulation, a host strain can be designed such that undesirable pathways are deactivated and 
cell growth is coupled to the operation of more desirable pathways.   Previously, Trinh et al. 
described a rational approach for strain design that involves calculation of EFMs in a metabolic 
network and sequential deletion of reactions to eliminate inefficient pathways (Trinh et al., 
2009).  This strategy was used to improve ethanol production from hexoses and pentoses by 
engineered E. coli (Trinh et al., 2008).  Here, we describe a distinct but related approach for 
systematic identification of gene deletion targets that may be beneficial for yeast metabolic 
networks. 
 The in silico rational design strategy is illustrated in Fig. 1.3 with the analysis of a 58-
reaction metabolic network for glucose fermentation by S. cerevisiae.  The network includes 
glycolysis, pentose phosphate pathway, TCA cycle, fermentation pathway, a biomass equation, 
and transport fluxes, as well as 47 internal metabolites at steady-state and seven external 
metabolites as sources or sinks (glucose, oxygen, carbon dioxide, ethanol, acetate, glycerol, and 
biomass).  In this example, our objective was to find reaction deletions that will constrain the cell 
to use the most efficient pathway for converting glucose to ethanol while maintaining sufficient 
biomass for cell growth.  The first step was to calculate the elementary modes for the given 
metabolic network with METATOOL or other appropriate software (Fig. 3a).  Second, the 1,918 
total modes were evaluated by calculating the ethanol yield and biomass yield for each, and then 
the modes were plotted to show their distribution in relation to these parameters (Fig. 3b).  Due 
to high ethanol yield and moderate biomass yield, 4 of the modes were classified as “good” 
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EFMs (i.e. desirable pathways) and the remaining 1,914 were classified as “bad” EFMs (i.e. 
undesirable pathways) for the objective.  Third, we identified a pool of 23 “bad” reactions that do 
not participate in the “good” EFMs and thus only contribute to the inefficient or undesirable 
pathways.  The key of the third step is to select a reaction target from the pool of “bad” reactions 
that is included in the most elementary modes in order to deactivate as many of the inefficient 
pathways as possible (Fig. 3c).  This step should be repeated to identify multiple deletion targets 
for minimizing undesirable modes.  In this case study, succinate dehydrogenase (SDH) was the 
best deletion target for accomplishing the objective and allowed elimination of almost 80% of 
the “bad” EFMs.  The second round of reaction deletion identified the acetate transporter 
(ACETt) as the best target and sequential deletion of the first two reactions reduced the number 
of undesirable modes to less than 5% of the original value.  In the third round, glucose-6-
phosphate dehydrogenase (G6PDH) was the best of the remaining targets and elimination of the 
first three reaction targets reduced the number of inefficient pathways to less than 1% of the 
original value (Fig. 3d).  Thus, the sequential deletion of three reactions (SDH, ACETt, G6PDH) 
eliminates a maximal number of undesirable modes and supports the operation of metabolic 
pathways for efficient glucose fermentation with sufficient biomass for cell growth.   
 
1.4  Combinatorial approaches for metabolic engineering 
Previously, we emphasized that metabolic engineering is a directed, or rational, approach 
for strain improvement.  However, one should not understand this to mean that random processes 
have no role in metabolic engineering of cells.  In fact, random mutations can be used to select 
superior strains which can provide a rich source of information about metabolic pathways and 
metabolic control (Stephanopoulos et al., 1998).  Inverse metabolic engineering is an important 
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and useful approach, which uses random genetic perturbations in combination with high 
throughput screening for identifying interesting metabolic engineering targets (Alper, 2006).   
 
1.4.1 Inverse metabolic engineering 
There are three basic steps involved in inverse metabolic engineering, which have been 
used together in many ways for elucidating strategies towards the directed engineering of useful 
phenotypes (Bailey et al., 1996).  The first step of this approach is the identification of some 
beneficial phenotype in a mutant strain.  The desired phenotype may occur naturally in the 
organism or through well-designed evolutionary engineering experiments.  Evolutionary 
engineering involves some spontaneous or induced mutations in a host strain and appropriate 
selection pressure for enriching fitter variants during cultivation in liquid or solid media (Çakar 
et al., 2012; Sauer, 2001).  Another option for generating mutant strains with beneficial 
phenotypes is the introduction of random genetic perturbations through a genomic DNA library 
(Hong et al., 2010; Lee et al., 2011) or randomized gene knockout library (Badarinarayana et al., 
2001).  Also, directed evolution has been very useful to generate diverse mutants with beneficial 
traits for inverse metabolic engineering; this approach involves random mutagenesis of a target 
gene, protein, or organism followed by gene recombination and screening or selection (Arnold, 
1998).  While screening of mutants can be tedious by conventional methods, tools such as flow 
cytometry or microfluidic devices have aided high-throughput screening and selection of 
interesting mutant strains (Alper, 2006; Wang et al., 2014).  The second step of inverse 
metabolic engineering involves determining the underlying genetic or molecular basis for a 
desired phenotype.  One of the great experimental advances towards this end is the significant 
increase in throughput and reduction in cost for genome sequencing (Gill, 2003).  Genome-wide 
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transcript analysis has also been used as a tool for uncovering changes responsible for superior 
cellular properties of a mutant strain (Bro et al., 2005).  As improvements in genomics 
technologies continue, it is expected that locating relevant gene sequences will no longer be a 
rate-limiting step of inverse metabolic engineering (Gill, 2003).  Finally, the third step of inverse 
metabolic engineering is to transfer the identified genetic perturbation(s) to another strain or 
organism for confirming the genotype-phenotype relationship.  Subsequently, the engineered 
strain may be further evolved or the strategy may be executed multiple times until arriving at the 
desired phenotype. 
 
1.5  Metabolic engineering of S. cerevisiae for production of fuels and chemicals 
For many centuries, S. cerevisiae has been widely employed for alcohol production, 
especially for human consumption.  This yeast is well-known to be one of the best ethanol-
producing organisms in nature.  Furthermore, S. cerevisiae is an attractive host for industrial 
bioprocesses due to high resistance to ethanol and other inhibitors and status as a GRAS 
organism (generally recognized as safe).  Based on its traditional importance in the food industry 
and recent applications in the field of biotechnology, a detailed knowledge of genetics, 
physiology, and biochemistry, as well as process technologies for large-scale fermentation, has 
accumulated over time.  S. cerevisiae was the first eukaryotic organism whose genome was 
completely sequenced (Goffeau et al., 1996) and now several databases exist containing a wealth 
of information about genes, open reading frames, and gene products (Nevoigt, 2008).  The 
availability of efficient transformation methods (Gietz and Schiestl, 2007a) and many genetic 
tools, such as specialized expression vectors and selectable markers, has facilitated advanced 
genetic engineering techniques (Nevoigt, 2008).  In addition, an extensive collection of systems 
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biology tools and metabolic reconstructions makes S. cerevisiae a desirable organism for in silico 
metabolic engineering.  A total of nine predictive genome-scale metabolic models have been 
created for S. cerevisiae in the last ten to fifteen years to provide a mathematical framework for 
analyzing the metabolic potential of this organism (Österlund et al., 2012), and the predictive 
power of these models has been validated against experimental data (Feist et al., 2008).  These 
are some of the major reasons that this host has been heavily utilized for various metabolic 
engineering studies. 
Several extensive and thorough review articles have been written on metabolic 
engineering of S. cerevisiae (Hong and Nielsen, 2012; Nevoigt, 2008; Ostergaard et al., 2000c).  
It is not the purpose of this section to give another exhaustive overview of the subject.  Rather, 
we intend to focus on the most impactful studies utilizing the systematic and/or combinatorial 
approaches discussed previously for enhancing bioconversion of sugars in renewable biomass.   
 
1.5.1 Bioethanol production from sugars in renewable biomass 
S. cerevisiae strains have long been selected for their ability to convert sugar to ethanol in 
order to make wine, beer, and other alcoholic beverages.  Thus, the yeast has evolved to 
efficiently consume glucose, which is the most abundant sugar in nature and a component of 
starch, fruits such as grapes, sucrose sources such as sugarcane, and cellulose and hemicellulose. 
However, it is known that glucose fermentation to ethanol is still not optimal, even under 
anaerobic conditions, because some carbon flux is directed towards glycerol, biomass, CO2, and 
other minor by-products (Bro et al., 2006; Nissen et al., 2000).  For example, an in silico model 
was used to identify strategies for reducing glycerol production in S. cerevisiae by preventing 
excess NADH through biomass synthesis.  The best strategy involved expression of a NADP
+
-
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dependent glyceraldehyde-3-phosphate dehydrogenase and resulted in a 40% lower glycerol 
yield but only 3% improvement in ethanol yield (Bro et al., 2006).  In another study, deletion of 
two key enzymes for glycerol synthesis, GPD1 and GPD2, eliminated glycerol production and 
increased ethanol yield from glucose about 12% during aerobic batch cultivations; however, the 
double knockout mutant also showed severe growth reductions (and no growth anaerobically) 
(Nissen et al., 2000).  Other research has shown that deletion of the glycerol facilitator FPS1, 
with or without glutamate synthase overexpression, also significantly reduces glycerol and 
increases ethanol production in S. cerevisiae (Kong et al., 2006).  Finally, petite mutants of yeast 
have also demonstrated usefulness for improving ethanol production from glucose (Bacila and 
Horii, 1979; Hutter and Oliver, 1998).  Petite mutants include any yeast strain with a DNA 
mutation resulting in inability to utilize non-fermentable carbon sources such as ethanol, 
glycerol, or acetate.  These respiration-deficient mutants can still grow on glucose or other 
fermentable carbon sources but form smaller colonies than wild type cells (Tzagoloff and 
Dieckmann, 1990). 
Xylose, which makes up a substantial portion of hemicellulose, is the second most 
abundant sugar in nature but is not able to be metabolized by native S. cerevisiae strains 
(Ostergaard et al., 2000c).  Over the last several decades, two main strategies have been 
employed for engineering xylose-utilizing mutants; both strategies require introduction of a 
heterologous pathway for converting xylose to xylulose, which can enter the pentose phosphate 
pathway.  The first strategy involves introduction of genes encoding xylose reductase (XR) and 
xylitol dehydrogenase (XDH) from the xylose-fermenting yeast Scheffersomyces stipitis and in 
some cases overexpression of an endogenous xylulokinase (XK) from S. cerevisiae (Jin et al., 
2000; Toivari et al., 2001).  The major challenges associated with this pathway are generally 
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redox imbalance and xylitol production, which are especially prevalent in anaerobic conditions.  
The first study to overcome the hurdle of anaerobic xylose utilization with this pathway made 
use of an evolutionary engineering strategy with selection of evolved strains by step-wise 
decreases in oxygen availability (Sonderegger and Sauer, 2003).  A more recent study 
engineered an efficient xylose-fermenting strain with minimal xylitol production by combining 
strong and balanced expression levels of the heterologous S. stipitis xylose utilization pathway 
and serial subcultures on xylose (Kim et al., 2013a).  Evolutionary engineering has also 
demonstrated utility for improving co-fermentation of xylose and arabinose to ethanol by 
recombinant S. cerevisiae expressing the XR/XDH pathway and a bacterial arabinose utilization 
pathway (Sanchez et al., 2010b).  Finally, a genomic DNA fragment library from S. stipitis was 
used to identify a beneficial overexpression target with high degree of homology to native S. 
cerevisiae TAL1 for a 70% increase in ethanol production from xylose (Jin et al., 2005).  The 
second general strategy for conversion of xylose to xylulose by yeast involves introduction of the 
xylose isomerase gene (xylA) from Piromyces or bacteria.  This is a one-step, redox-neutral 
pathway but it is not energetically favorable compared to the XR/XDH pathway (Karhumaa et 
al., 2007).  For recombinant S. cerevisiae strains expressing fungal xylose isomerase, 
evolutionary engineering has been effective in numerous studies for improving fermentation 
parameters during growth on xylose (Kuyper et al., 2004; Shen et al., 2012; Zhou et al., 2012) or 
a mixture of xylose and other sugars (Kuyper et al., 2005; Wisselink et al., 2009).  In another 
study, directed evolution generated a mutant xylose isomerase with a 77% increase in enzymatic 
activity and the mutant gene led to an 8-fold increase in xylose uptake rate and ethanol 
productivity (Lee et al., 2012). 
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Galactose is abundant in some marine plant biomass, but utilization of this sugar by S. 
cerevisiae is relatively slow and inefficient.  Although capable of growing on galactose, its 
galactose uptake rate is approximately three times lower than that on glucose and ethanol yield is 
also significantly lower (Ostergaard et al., 2000d).  To overcome this deficiency, one study 
attempted to modify the GAL gene regulatory network in S. cerevisiae, which is a tightly 
regulated system.  They found that deletion of three negative regulators of the GAL system 
(Gal6, Gal80, Mig1) led to a 41% increase in galactose pathway flux, which was the best among 
the mutants tested (Ostergaard et al., 2000a).  A follow-up study used transcript analysis to 
identify phosphoglucomutase (PGM2) as an overexpression target resulting in a 70% increase in 
galactose uptake rate as compared to the reference strain (Bro et al., 2005).  Another group 
employed a genome-wide perturbation library to discover SNR84 (coding for a small nuclear 
RNA) and truncated TUP1 (coding for a general repressor of transcription) as overexpression 
targets for improving galactose fermentation as much as PGM2 overexpression
 
(Lee et al., 2011).  
Finally, a recent article reported that adaptive evolution with a laboratory strain over many 
generations was useful for increasing galactose uptake rate and growth rate in S. cerevisiae; 
furthermore, this approach led to identification of unknown and unexpected genetic targets 
(Hong et al., 2011a).  
 
1.5.2 Production of other fuels and chemicals from sugars in renewable biomass 
Besides ethanol, metabolic engineering approaches have also been useful for developing 
S. cerevisiae cell factories with increased carbon flux toward one of a wide variety of other fuels 
or chemicals.  For example, a systematic model-based approach was employed to identify a key 
deletion target (GDH1) in yeast for enhancing NADPH availability and improving sesquiterpene 
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synthesis from galactose by 85%.  Although the knockout strain (∆gdh1) showed a significant 
reduction in growth rate, subsequent overexpression of GDH2 maintained product titer with less 
growth penalty (Asadollahi et al., 2009).  In another study, an in silico gene deletion simulation 
was effective for selecting two knockout targets (PDC1 and GDH1) involved in vanillin 
production, and the best knockout strain (∆pdc1) improved vanillin productivity by a factor of 2 
in glucose-limited continuous culture (Brochado et al., 2010b).  More recently, flux balance 
analysis led to a metabolic engineering strategy for overproduction of succinate which involved 
deletion of SDH3 (encoding the primary succinate consuming reaction in the TCA cycle) and 
SER3/SER33 (encoding 3-phosphoglycerate dehydrogenase).  When combined with adaptive 
evolution, the resulting S. cerevisiae strain produced 30-fold more succinate than the control 
strain with a 2.8-fold decrease in specific growth rate (Otero et al., 2013).  Also, EFM analysis 
was applied for evaluating the effect of network modifications and changing culture conditions 
on poly-β-hydroxybutyrate (PHB) production in recombinant yeast including a PHB synthesis 
pathway.  The results of the study showed that adding an ATP citrate-lyase reaction and a 
transhydrogenase reaction to the metabolic network increased maximum theoretical PHB yield 
from 0.67 to 0.84 (Carlson et al., 2002).  In addition to the model-based techniques, various 
combinatorial methods have also been successful for improving biosynthesis of fuel and 
chemicals by engineered S. cerevisiae.  For example, after deletion of four genes (TPI1, NDE1, 
NDE2, and GUT2) identified by rational means, evolutionary engineering led to a glycerol-
producing strain with almost maximum product yield from glucose (Overkamp et al., 2002).  
Another group constructed a pyruvate decarboxylase-negative strain and used a two-step 
evolutionary engineering approach to develop glucose-tolerant, pyruvate-producing yeast with 
product yield of 0.54 g/g glucose (van Maris et al., 2004).  Finally, Ishida et al. utilized an 
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evolutionary engineering approach with a starting strain expressing six copies of lactate 
dehydrogenase and thereby achieved 122 g/L of lactate production (Ishida et al., 2006). 
 
1.6 Concluding remarks and future perspectives 
The systematic model-based approaches, which are based on network stoichiometry, 
provide a valuable tool for system-wide analysis of metabolism, gene target identification, and 
phenotype prediction under specified conditions.  A major advantage of these systematic 
approaches is in providing a cheaper and faster way to narrow an extensive set of candidate gene 
targets without costly and time-consuming initial wet experiment screening.  However, it is 
important to note that stoichiometric models usually do not account for kinetic and regulatory 
effects that may significantly impact in vivo results, and they require a significant accumulation 
of knowledge about an organism’s metabolic capabilities and interactions within its complex 
biomolecular network.  Thus, the model-based methods are somewhat limited and should 
generally be used in combination with other approaches.  On the other hand, inverse metabolic 
engineering is a powerful combinatorial approach for identifying novel gene targets responsible 
for a desired phenotype.  A particular advantage of this technique is unique access to still poorly 
understood cellular subsystems, unknown regulatory genes, or non-coding regions that are 
critical for cellular function (Alper, 2006; Sauer and Schlattner, 2004); perturbation targets in 
these categories could not be identified by a systematic approach like stoichiometric modelling.  
In the past, the main challenge associated with many combinatorial engineering studies was in 
discerning the genetic basis responsible for a desirable phenotype in some mutant strain (Bailey 
et al., 1996).  However, rapid and on-going advances in genomics technologies have greatly 
improved the ability to gain understanding about novel or interesting mutant yeast strains.  The 
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various applications discussed in this review demonstrate the capability for systematic and 
combinatorial methods to reveal previously unknown perturbation targets for strain development 
and improvement.  Due to continued efforts in these areas, we expect to see significant advances 
in research and definite progress toward commercialization of yeast-derived biofuels and 
biochemicals (Kim et al., 2012).   
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1.7  Figures 
 
Fig. 1.1 Systematic approaches for metabolic engineering of microorganisms. (a) A 
stoichiometric model is based on a metabolic network of reactions and a mass balance around 
each of the intracellular metabolites. Under steady state conditions, there is no net accumulation 
of metabolites and the model can be simplified to a system of algebraic expressions (S ∙ ν = 0). 
(b) Flux balance analysis allows an explicit prediction of metabolic phenotype by defining some 
reaction constraints and applying an objective function to solve the balance equation. (c) 
Metabolic pathway analysis calculates all feasible solutions that exist in a metabolic network by 
solving the balance equation with an additional non-decomposability constraint. 
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Fig. 1.2 Combinatorial approaches for metabolic engineering of microorganisms. Inverse 
metabolic engineering involves random genetic perturbations in combination with high 
thoughput screening for identifying interesting genetic targets.  Spontaneous or induced 
mutations are commonly introduced to a host strain or gene fragment by (a) evolutionary 
engineering, (b) genomic DNA libraries, or (c) directed evolution. 
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Fig. 1.3 Rational in silico design strategy for identifying deletion targets by EFM analysis. (a) 
Calculate EFMs for the metabolic network. (b) Evaluate the modes based on the metabolic 
objective and then classify modes into categories (e.g. “good” vs. “bad”). (c) Identify the 
reaction that includes the most undesirable or “bad” EFMs. (d) Sequentially determine multiple 
knockout targets in order to minimize the inefficient pathways. 
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2.1   Introduction 
Saccharomyces cerevisiae, or baker’s yeast, is the preferred microorganism for industrial 
ethanol fermentation since this species has long been employed by the food industry to convert 
sugar into alcohol (Nevoigt, 2008).  In addition to its industrial importance, bioethanol 
production in yeast is also an excellent model system for probing of genotype-phenotype 
relationships and discovering genetic perturbations for optimization of metabolic flux through 
central carbon metabolism (Dikicioglu et al., 2008).  S. cerevisiae and many other organisms first 
catabolize hexoses (e.g. glucose, fructose, mannose) through the glycolytic pathway with 
pyruvate as the end product.  In turn, pyruvate can be reduced to ethanol via a two-step 
fermentative pathway.  Alternatively, in the presence of oxygen, pyruvate may be completely 
oxidized to carbon dioxide via tricarboxylic acid (TCA) cycle enzymes, which results in transfer 
of electrons to oxygen and ATP generation (Sonnleitner and Käppeli, 1986).  It is well-known 
that S. cerevisiae can grow and remain viable in anaerobic conditions without oxidative 
degradation of pyruvate because some ATP is generated during glycolysis.  However, when even 
small amounts of oxygen are present, some of the carbon source will be metabolized oxidatively 
(cellular respiration).  In Crabtree positive yeasts such as S. cerevisiae, a low external glucose 
concentration is more conducive to the respiratory metabolism than a very high glucose 
concentration.  The cellular respiration process is more efficient than fermentation in terms of net 
energy payback to the cell but is counterproductive for the goal of optimal ethanol production.  
Similarly, S. cerevisiae can also direct carbon flux toward synthesis of other fermentation by-
products such as glycerol or acetate in order to maintain redox balance within the cells 
(Costenoble et al., 2000; Remize et al., 2000).  Therefore, we hypothesized that elimination of 
some unknown reactions may shift carbon flux away from the undesirable pathways (i.e. TCA 
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cycle, glycerol/acetate synthesis, etc.) and increase the ethanol-producing capability of the 
organism.  It is important that any deleted reaction(s) should not lead to undesirable side effects 
caused by unknown interactions in the system.  For example, a previous metabolic engineering 
study described yeast knockout strains with increased ethanol yield on glucose, but the strains 
were accompanied by a substantial reduction in specific growth rate (Nissen et al., 2000).  The 
objective of this study was to engineer S. cerevisiae towards optimal ethanol fermentation with 
minimal impact on growth phenotype by using a genome-scale metabolic model to 
systematically guide the identification of novel gene deletion targets.   
The yeast S. cerevisiae was the first eukaryotic organism whose genome was completely 
sequenced and now several databases exist containing a wealth of information about genes, open 
reading frames, and gene products (Goffeau et al., 1996; Nevoigt, 2008).  The availability of 
very efficient transformation methods and many genetic tools, such as specialized expression 
vectors and selectable markers, has facilitated advanced genetic engineering techniques (Gietz 
and Schiestl, 2007b).  In addition, an extensive collection of systems biology tools and metabolic 
reconstructions makes S. cerevisiae an amenable microorganism for in silico metabolic 
engineering.  A total of six predictive genome-scale metabolic models have been created in the 
last fifteen years to provide a mathematical framework for analyzing the metabolic potential of 
this organism, and the predictive power of these models has been validated against experimental 
data (Feist et al., 2008; Nookaew et al., 2011).  Constraint-based flux analysis (or flux balance 
analysis) is a proven mathematical approach for application of the genome-scale models in order 
to predict phenotypic results and identify gene targets for metabolic engineering.  This method 
only requires information about reaction stoichiometry, metabolic requirements for growth, and a 
few other strain-specific parameters without any of the difficult-to-measure kinetic parameters 
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that are required for more theoretical approaches (Orth et al., 2010; Varma and Palsson, 1994).  
An optimal flux distribution representing the strain’s predicted phenotype under defined 
conditions can be calculated based on specified reaction constraints and an objective function, 
which is generally accepted to be biomass maximization in microorganisms (Edwards et al., 
2001; Famili et al., 2003).  The main advantage of using stoichiometric modeling techniques is 
for providing an efficient way to narrow large sets of candidate genes without costly and time-
consuming initial wet experiment screening of extensive gene sets.  Inspired by the fact that 
stoichiometric models have been successfully applied to study and improve production of a 
variety of value-added products in S. cerevisiae (Asadollahi et al., 2009; Bro et al., 2006; 
Brochado et al., 2010a; Ng et al., 2012), we hypothesized that a model-based approach could be 
used to generate new metabolic engineering strategies for enhancing ethanol fermentation in this 
yeast. 
For accomplishing the objective, we used the genome-scale stoichiometric model 
iND750 (Duarte et al., 2004a) to evaluate the effect of gene deletion on ethanol production in 
yeast.  A single gene deletion simulation was conducted at various oxygen uptake rates, and the 
in silico knockout phenotypes were scanned for improvement in ethanol production while 
maintaining sufficient biomass for cell growth.  Twenty potential gene targets linked to two 
enzymes in the electron transport chain (cytochrome c oxidase, ubiquinol cytochrome c 
reductase) were identified for further evaluation. Though stoichiometric modeling is a powerful 
tool for in silico metabolic engineering, it is important to note that neither constraint-based flux 
analysis nor the iND750 model accounts for kinetic and regulatory effects that may significantly 
impact in vivo results.  It is possible that genetic regulation may outweigh stoichiometric effects 
in certain situations and thus lead to unexpected results (Alper et al., 2005a).  To overcome this 
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limitation and compare all knockout targets identified by the gene deletion simulation, laboratory 
screening was conducted in shake flask experiments with minimal media.  The combination of a 
model-based gene targeting strategy and experimental screening led to identification of three 
outstanding single knockout strains for improving ethanol production on glucose in microaerobic 
conditions.  The beneficial effects of these mutant strains were demonstrated on two other 
common hexoses (fructose and mannose) and a disaccharide (sucrose).  Furthermore, this study 
describes the significant variation in phenotype among respiration-deficient mutants of S. 
cerevisiae and provides knowledge of specific genetic targets for optimizing ethanol production 
coupled with cell growth. 
 
2.2 Materials and methods 
 
2.2.1  In silico design   
The S. cerevisiae genome-scale metabolic model iND750 was used in this study (Duarte 
et al., 2004a).  The model contains 750 genes and 1,266 associated reactions, including 1,149 
intracellular reactions, 116 membrane exchange fluxes, and a biomass equation. 
Compartmentalization of 646 unique metabolites in the cell, which have been assigned to one of 
eight cellular compartments (cytosol, mitochondrion, peroxisome, nucleus, endoplasmic 
reticulum, Golgi apparatus, and vacuole), results in 1,059 total species in the model that are all 
stoichiometrically balanced.  The dimensions of the stoichiometric matrix are therefore 1,059 
metabolites by 1,266 reactions.  The exchange fluxes for the following metabolites were 
unconstrained in the model to assume excess for simulating minimal media conditions: NH4
+, 
SO4
-, K+, Na+, PO4
3-, and H2O.  Glucose was the sole carbon source with an uptake rate of 5 
mmol/gDW∙hr, and the non-growth associated ATP maintenance requirement was constrained to 
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1 mmol/gDW∙hr (Stouthamer, 1979).  Oxygen uptake rates were constrained in the model to 
appropriate values for yeast fermentation in oxygen-limited conditions (see Results section).   
The COBRA (constraint-based reconstruction analysis) toolbox is a software package and 
valuable systems biology tool allowing for predictive computations of cellular metabolism using 
constraint-based models (Becker et al., 2007).  All gene deletion simulations in this study were 
conducted using the singleGeneDeletion function in the COBRA toolbox.  This function 
constrains the flux to zero for the reaction(s) corresponding to a deleted gene based on gene-
reaction associations in the model; then, the algorithm calculates a metabolic flux distribution by 
applying an objective function and defined reaction constraints.  The constraint-based flux 
analysis was performed using linear programming library GLPK (http://ftp.gnu.org/gnu/glpk/) in 
MATLAB (2010b, Mathworks, Natick, MA) with maximization of biomass as the objective 
function. 
 
2.2.2  Strains and knockout strain construction   
S. cerevisiae strains BY4742 (MATalpha, leu2, his3, ura3, lys2), CEN.PK2-1D 
(MATalpha, leu2, his3, ura3, trp1), and JAY291 (MATa) (Argueso et al., 2009) were used in this 
study as control strains and for engineering of knockout strains.  Single knockout mutants with 
BY4742 background were obtained from Yeast Knockout MATalpha Collection 
(OpenBiosystems, Lafayette, CO).  The COX9 deletion cassette with KanMX marker was cloned 
from BY4742 ∆cox9 by PCR with primers COX9-f and COX9-r.   The QCR6 deletion cassette 
with KanMX marker was cloned from BY4742 ∆qcr6 by PCR with primers QCR6-f and QCR6-
r.  The QCR9 deletion cassette with KanMX marker was cloned from BY4742 ∆qcr9 by PCR 
with primers QCR9-f and QCR9-r.  All primers were obtained from Integrated DNA 
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Technologies (Coralville, IA) and are listed in Table 2.1.  The deletion cassette was then 
integrated into the genome of CEN.PK2-1D or JAY291 strain by transformation using the EZ-
Transformation kit (BIO 101, Vista, CA) or a high efficiency lithium acetate protocol (Gietz and 
Schiestl, 2007b).  Positive transformants were selected by G418 resistance on YPD agar plates.  
Gene deletion was confirmed by colony PCR with confirmation primers Cd-f and KanMX-r for 
COX9 deletion, primers Q6d-f and KanMX-r for QCR6 deletion, or primers Q9d-f and KanMX-r 
for QCR9 deletion (Table 2.1).  
 
2.2.3  Media and culture conditions 
To prepare yeast strains for inoculation, cells were cultivated overnight at 30°C and 250 
RPM in YPD medium (10 g/L yeast extract, 20 g/L Bacto peptone, 20 g/L glucose).  Batch 
fermentation was carried out at 30°C and 100 RPM in yeast synthetic complete (YSC) medium 
(1.7 g/L yeast nitrogen base, 5 g/L ammonium sulfate, and 0.79 g/L Complete Supplement 
Mixture (MP Biomedicals, Solon, OH) for supplying amino acids and nucleobases) with 40 g/L 
of the appropriate sugar (glucose, fructose, sucrose, or mannose).  To select yeast transformants 
with the KanMX marker, a YPD agar plate was used with 200 μg/mL of G418.  
 
2.2.4  Fermentation experiments 
Yeast pre-cultures were grown with 5 mL of YPD medium in an orbital shaker at 30°C to 
prepare inoculums for fermentation experiments.  Cells in exponential phase were harvested and 
inoculated after removing used YPD.  Flask fermentation experiments were performed using 25 
mL (or 50 mL) of YSC medium with 40 g/L of the appropriate sugar in a well-controlled shaking 
incubator (Thermoscientific, MaxQ4000, Dubuque, IA) under oxygen-limited conditions.  Initial 
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cell densities were adjusted to OD600 of ~0.1.  During the course of the fermentation, the 
temperature and agitation rate were kept constant at 30°C and 100 RPM, respectively.     
 
2.2.5  Analytical methods   
Cell concentration was measured by optical density (OD) at 600 nm using a UV-visible 
spectrophotometer (Biomate 3, Thermoscientific, Madison, WI).  The concentration of sugar, 
ethanol, glycerol, and acetate in batch fermentations was determined by a high-performance 
liquid chromatography system (Agilent Technologies 1200 series) with a refractive index 
detector (RID) and a Rezex ROA-Organic Acid H+ column (Phenomenex Inc., Torrance, CA).  
The column temperature was kept constant at 50°C and the elution was performed with 0.005 N 
H2SO4 at a flow rate of 0.6 ml/min.   
 
2.3  Results  
 
2.3.1  In silico gene deletion simulations  
The S. cerevisiae iND750 genome-scale model accounts for 750 genes associated with 
1266 metabolic reactions (including membrane exchange fluxes) and 1061 internal and external 
metabolites (eight cellular compartments).  In order to obtain reliable predictions, it is important 
to consider which metabolic state(s) should be used to most accurately constrain the model.  For 
example, the yeast S. cerevisiae is well-known to adjust to external oxygen availability by using 
respiratory and/or fermentative metabolic modes (Jouhten et al., 2008); therefore, varying the 
oxygen uptake rate (OUR) in silico can have a significant effect on model predictions.  Based on 
previous studies with a yeast genome-scale metabolic model (Duarte et al., 2004b), the oxygen 
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uptake rate was varied from 0 to 20 mmol/gDW∙hr to determine the effect of this variable on 
cellular metabolism and identify an appropriate range for model simulations.  For all model 
simulations, glucose was the sole carbon source (uptake rate = 5 mmol/gDW∙hr) and flux 
constraints were adjusted for minimal media.  Under complete anaerobic conditions (OUR = 0), 
the iND750 model predicted a low maximum specific growth rate (0.0853 hr-1) and high ethanol 
yield and productivity (0.424 g ethanol/g glucose; 8.288 mmol/gDW∙hr), which is in accordance 
with fermentative metabolism.  As the oxygen uptake rate increased to a saturation point (OUR = 
12.5 mmol/gDW∙hr), the model predicted a shift towards respiratory metabolism with the 
maximum specific growth rate increasing to its maximum value (0.478 hr-1) and ethanol 
production rate decreasing to zero.  Four different oxygen uptake rates at <1 mmol/gDW∙hr were 
selected to mimic microaerobic conditions for all subsequent gene deletion simulations; these 
values were chosen after comparing in silico ethanol yields with typical flask fermentation 
results in oxygen-limited conditions.  
The gene deletion simulation was conducted at the oxygen uptake rate values of interest 
using the COBRA toolbox, and the in silico yields of ethanol, glycerol, and biomass were 
calculated as criteria for screening the 750 knockout mutants.  In most cases, biomass yield and 
ethanol yield are inversely related, so knockout target selection must strike a balance between 
improving ethanol production and maintaining sufficient biomass synthesis for cell growth.  We 
searched for deletion targets predicting an increase in ethanol yield while maintaining at least 
80% of the wild type cell’s biomass yield.  Twenty such genes were identified and are listed in 
Table 2.2 with the gene name, related enzyme, and enzyme classification.  All 20 genes are 
linked to two oxidative phosphorylation enzymes, cytochrome c oxidase (COX) and ubiquinol 
cytochrome c reductase (QCR), which are both critical for the cell’s respiratory metabolism.  The 
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model predicts an identical flux distribution for each of the twenty knockout strains and thus an 
equal degree of improvement towards the objective.  Fig. 2.1a shows a plot of the in silico 
ethanol and biomass specific productivity versus oxygen uptake rate for the wild-type strain and 
all twenty mutants from Table 2.2.  When comparing the mutant phenotypes to the wild type, the 
model predictions show an increasing improvement in ethanol yield and increasing reduction in 
biomass yield at higher oxygen uptake rates (Fig. 2.1b).  Under anaerobic conditions, the wild 
type and mutant strains have the same flux distribution.  At an oxygen uptake rate of 1 
mmol/gDW/hr, the in silico ethanol yield and biomass yield of the knockout strains are 4% 
higher and 20% lower than the wild type, respectively.  The results from the model-based 
simulations seem to indicate that COX-related genes and QCR-related genes may be good 
deletion targets for improving glucose fermentation to ethanol in oxygen-limited or fully aerobic 
conditions. 
 
2.3.2  Experimental screening of knockout mutants 
In order to validate the in silico results and determine the effect of various subunits on 
overall enzyme function, a total of eighteen cytochrome c oxidase (COX) single knockout 
mutants and nine ubiquinol cytochrome c reductase (QCR) single knockout mutants were 
screened by flask fermentation in glucose minimal media.  Fig. 2.2a and Fig. 2.2b show the 
average percent change in ethanol production rate and biomass yield as compared to control 
strain BY4742 for each of the COX knockout strains and QCR knockout strains, respectively.  
The eighteen COX mutants that were evaluated are deficient in one of the following genes: any 
of six out of the ten COX genes identified by the in silico gene deletion study (Table 2.2) or any 
of twelve other COX genes not included in the iND750 model.  Four of the ten COX genes 
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identified by the in silico simulation were either mitochondrial genes (COX1, COX2, COX3) or 
resulted in a lethal knockout phenotype (COX4) and therefore could not be deleted in vivo.  The 
nine QCR mutants that were evaluated are deficient in any one of the QCR genes predicted by 
the model-based simulation (Table 2.2) except for COB, which is a mitochondrial gene and thus 
could not be deleted. 
Fig. 2.2 clearly illustrates that all deletion mutants did not have a similar phenotype.  
However, in qualitative agreement with the model-based predictions, twelve of the eighteen 
COX mutants (∆cox6, ∆cox8, ∆cox9, ∆cox10, ∆cox12, ∆cox14, ∆cox16, ∆cox17, ∆cox18, 
∆cox20, ∆cox23, ∆cox25) and seven of the nine QCR mutants (∆cor1, ∆cyt1, ∆qcr2, ∆qcr6, 
∆qcr7, ∆qcr9, ∆qcr10) did show an improvement in ethanol production rate and a reduction in 
biomass yield as compared to the control strain.  Among the eighteen COX mutants, BY4742 
∆cox9 stood out as the best strain for our objective with the largest increase in ethanol production 
rate; the ethanol-producing performance of this strain exceeded the second best COX deletion 
strain BY4742 ∆cox12 by a factor of approximately two.  The BY4742 ∆cox9 strain consumed 
glucose at a 22% faster rate and showed a 12% increase in ethanol yield over the control strain; 
however, the ∆cox9 mutant also showed a significant loss in final cell density (P < 0.05).  The 
complete fermentation profiles for BY4742 and BY4742 ∆cox9 are displayed in Fig. 2.3a and 
Fig. 2.3b, respectively.  Among the nine QCR mutants, BY4742 ∆qcr9 was the best strain in 
terms of ethanol production rate.  The BY4742 ∆qcr9 strain had an 18% faster glucose 
consumption rate and a 7% higher ethanol yield when compared to the control strain.  In 
addition, we also observed that BY4742 ∆qcr6 was the best of the QCR mutants in terms of 
ethanol production rate coupled with biomass yield.  This was especially interesting because 
deletion of either COX9 or QCR9 seemed to have some negative effect on cell growth.  The 
 37 
 
BY4742 ∆qcr6 mutant showed no significant reduction in maximum specific growth rate or final 
cell density but still consumed glucose 17% faster and produced ethanol with a 6% higher yield 
than BY4742. 
 
2.3.3  Evaluation of ∆cox9, ∆qcr6, and ∆qcr9 mutations in CEN.PK2-1D background 
To determine whether or not the observed improvement in ethanol yield and productivity 
by BY4742 ∆cox9, BY4742 ∆qcr6, and BY4742 ∆qcr9 is strain-specific, we deleted COX9, 
QCR6, and QCR9 in the laboratory strain CEN.PK2-1D.  Geneticin (G418) resistance and colony 
PCR were used to confirm successful gene deletion.  In flask fermentations with glucose 
minimal media, the engineered strains CEN.PK2-1D ∆cox9, CEN.PK2-1D ∆qcr6, and 
CEN.PK2-1D ∆qcr9 showed improvement in ethanol production rate as compared to the control 
strain by 33%, 36%, and 38%, respectively.  Furthermore, deletion of COX9, QCR6, and QCR9 
in CEN.PK2-1D background improved ethanol yield by 10%, 13%, and 15%, respectively.  
Interestingly, the CEN.PK2-1D ∆qcr6 strain also showed no significant reduction in maximum 
specific growth rate or final cell density versus the control strain.  While the ∆cox9 and ∆qcr9 
mutants grew slower than the control during the lag phase and early exponential phase of the 
fermentation, the ∆qcr6 strain maintained a similar or even slightly higher cell density.  Fig. 2.3c 
and Fig. 2.3d display the related fermentation profiles for the ∆qcr6 and ∆qcr9 mutants in 
CEN.PK2-1D background.  Also, Table 2.3 presents a summary of the glucose consumption rate, 
ethanol yield, and ethanol production rate by the wild type, ∆cox9 mutant, ∆qcr6 mutant, and 
∆qcr9 mutant in both BY4742 and CEN.PK2-1D strains.  The results demonstrate that the 
beneficial effects of these three deletions during glucose fermentation are general to S. cerevisiae 
and not specific to any particular strain. 
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2.3.4  Evaluation of ∆cox9, ∆qcr6, and ∆qcr9 mutants on other hexoses   
Fructose, sucrose, and mannose are three other hexoses abundant in nature that can be 
fermented to ethanol by S. cerevisiae.  We were interested to evaluate the identified single 
knockout mutants on these three hexoses to determine if the improvement in ethanol production 
rate and ethanol yield on glucose would extend to other sugars with a similar metabolism as 
glucose. Therefore, we conducted another series of flask fermentations with the knockout strains 
BY4742 ∆cox9, BY4742 ∆qcr6, and BY4742 ∆qcr9 in minimal media with 40 g/L of fructose, 
sucrose, or mannose as the sole carbon source.  The ethanol production rate, ethanol yield, and 
final cell density for the wild type and all three mutant strains is summarized in Fig. 2.4a, Fig. 
2.4b, and Fig. 2.4c, respectively; the figure includes results for all four hexoses used in this study 
including glucose results discussed previously.  Fig. 2.4a shows that each of the three knockout 
strains showed a significant improvement (P < 0.05) in ethanol production rate on glucose, 
fructose, mannose, or sucrose.  Furthermore, all of the knockout strains had a higher average 
ethanol yield than the control on each carbon source (Fig. 2.4b); the BY4742 ∆qcr6 strain on 
glucose was the only case where this improvement in ethanol yield was not statistically 
significant (P = 0.087).  Finally, the BY4742 ∆cox9 strain had a significant reduction (P < 0.05) 
in final cell density for each of the four hexoses while BY4742 ∆qcr6 had no significant change 
in final cell density for any hexose (Fig. 2.4c).  The results clearly demonstrate that the 
outstanding characteristics of the three knockout strains identified in this study may be extended 
to a variety of fermentable sugars in microaerobic conditions. 
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2.3.5  Growth on non-fermentable carbon source 
The ∆cox9, ∆qcr6, and ∆qcr9 mutants were streaked onto YP glycerol plates to compare 
growth on a non-fermentable carbon source.  Fig. 2.5 shows the results in both BY4742 and 
CEN.PK2-1D background.  In both cases, the ∆cox9 and ∆qcr9 mutants were not able to grow at 
all, which indicates a complete respiration deficiency by these knockout strains.  However, the 
∆qcr6 mutant did show some growth on glycerol, although the colony size was considerably 
smaller than for the wild-type strain.  This indicates only a partial respiration deficiency by 
deleting QCR6 and explains why the ∆qcr6 mutant was able to grow better than either ∆cox9 or 
∆qcr9 during hexose fermentation. 
 
2.3.6  Industrial strain fermentation with high initial glucose concentration 
In order to evaluate the knockout strains in a condition where more fermentation takes 
place, we conducted another experiment using the industrial S. cerevisiae strain JAY291, which 
consumes glucose much faster (2.93 g/L∙hr) and also produces ethanol much faster (1.21 g/L∙hr) 
than either of the laboratory strains used previously (BY4742 or CEN.PK2-1D).  We proceeded 
to delete QCR6 and QCR9 in the JAY291 background and then evaluated the mutants (∆qcr6 
and ∆qcr9) in minimal media with a high initial glucose concentration (100 g/L).  We chose to 
omit COX9 deletion in JAY291 since deletion of QCR9 and deletion of COX9 resulted in a 
similar growth phenotype for the laboratory strains.  Fig. 2.6 shows the results for the high-sugar 
industrial strain fermentation.  Although the improvement by our knockout mutants is reduced in 
these highly fermentative conditions, we still see a higher average ethanol production rate (9-
12%) and higher glucose consumption rate (9-10%) by JAY291 ∆qcr6 or JAY291 ∆qcr9 as 
compared to the control.  For both mutants, the improvement in glucose consumption rate was 
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statistically significant (P < 0.05).  However, the increase in average ethanol production rate was 
not statistically significant at the 95% confidence interval for JAY291 ∆qcr6 (P = 0.109) or 
JAY291 ∆qcr9 (P = 0.055).  There was almost no improvement in ethanol yield by the knockout 
strains under these conditions.  The JAY291 ∆qcr6 and JAY291 ∆qcr9 strains both grew as well 
as the control throughout the fermentation and actually showed a slightly higher final cell 
density. 
 
2.4  Discussion 
Rapid and efficient hexose fermentation by S. cerevisiae with maximum yield and 
productivity of ethanol is important for many food and fuel applications.  In addition, the ethanol 
production pathway is also an excellent model system for optimization of metabolic flux through 
central carbon metabolism.  In this study, we employed an in silico genome-scale metabolic 
model to identify and select knockout targets for improving ethanol production in yeast while 
maintaining acceptable overall growth rate.  The model-based strategy allowed us to narrow an 
extensive gene set and systematically guided us to consider genes encoding two oxidative 
phosphorylation enzymes, which catalyze the last two reactions in the respiratory electron 
transport chain.  Ubiquinol cytochrome c reductase (EC 1.10.2.2) and cytochrome c oxidase (EC 
1.9.3.1), also known as complex III and complex IV in the electron transport chain, are integral 
membrane proteins in the mitochondrial membrane which are critical for aerobic life due to their 
ability to maintain a proton gradient and thus synthesize ATP (Brunori et al., 2005).  In S. 
cerevisiae, it is known that the ubiquinol cytochrome c reductase (QCR) enzyme contains ten 
non-identical subunits and is responsible for transferring electrons from reduced ubiquinone to 
ferricytochrome c (Shi et al., 2001).  Subsequently, the cytochrome c oxidase (COX) enzyme, 
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which possesses eleven distinct subunits and depends on a number of other related proteins for 
assembly and activity, transfers electrons from ferrocytochrome c to oxygen and thus catalyzes 
the reduction of oxygen to water (Geier et al., 1995).  The Saccharomyces Genome Database 
(Cherry et al., 2012) contains a wealth of information about genes that are directly or indirectly 
associated with these two multi-subunit enzymes.  In this study, the stoichiometric model-based 
simulation predicted that deletion of any one of the multiple genes encoding the COX enzyme or 
QCR enzyme would have an identical effect on phenotype (Fig. 2.1).  While stoichiometric 
modeling was useful for narrowing a large set of gene targets, this approach was not sufficient to 
distinguish between multiple genes linked to a single enzyme because the metabolic model does 
not account for genetic regulation and other unknown potential cellular interactions.  
Distinguishing between the twenty gene targets in Table 2.2 is where the utility of the in silico 
model ends and the need for experimental screening begins.  To our knowledge, no previous 
work has been done to evaluate and compare the phenotypic effect in S. cerevisiae by in vivo 
deletion of each one of the QCR-related genes or COX-related genes identified by our model-
based gene targeting strategy.   
Eighteen COX single knockout mutants and nine QCR single knockout mutants were 
screened by glucose fermentation in oxygen-limited conditions to evaluate the model predictions.  
Over two-thirds of the knockout mutants identified by the in silico study exhibited experimental 
behavior qualitatively consistent with model predictions; however, the notable exceptions 
illustrate the danger of using a purely stoichiometric model-based approach.  The experimental 
screening results demonstrate a high degree of variability among the phenotypes of QCR and 
COX single knockout mutants (Fig. 2.2) and indicate that the individual subunits contribute to 
the overall function of the enzyme complexes in very different ways.  For the nine QCR single 
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deletion mutants, the average change in ethanol production rate was a 16% increase and the 
average change in biomass yield was a 9% decrease as compared to the control strain.  This 
result indicates a qualitative fit of experimental data with model predictions.  However, the best 
QCR-related ethanol-producing strain (∆qcr9) increased ethanol production rate by 27% and 
reduced biomass yield by 20%; the worst QCR-related ethanol-producing strain (∆rip1) 
decreased ethanol production rate by 15% and increased biomass yield by 15%.  The model-
based gene targeting strategy was unable to predict these variations among QCR-related gene 
deletion mutants or to identify the most outstanding single knockout mutants.  The data in Fig. 
2.2, showing the variable effect of QCR and COX gene deletions on ethanol production rate and 
biomass yield, could be used to build a more accurate genome-scale metabolic model of S. 
cerevisiae. 
Many previous studies have reported that utilizing respiration-deficient yeast strains, or 
petite mutants, can improve ethanol production efficiency (Bacila and Horii, 1979; Hutter and 
Oliver, 1998; Kim et al., 2010).  Petite mutants include any yeast strain with a nuclear DNA 
mutation resulting in inability to utilize non-fermentable carbon sources such as ethanol, 
glycerol, or acetate.  Petite mutants can still grow on glucose or other fermentable carbon sources 
but form smaller colonies than wild type cells (Tzagoloff and Dieckmann, 1990).  For industrial 
ethanol production, two of the major advantages of respiration deficiency include: (i) elimination 
of oxidative metabolism of sugars and other fermentation products, and (ii) more leniency in 
fermentation conditions since a strict anaerobic environment is no longer required.  Though it is 
well known in a general sense that respiration inhibits fermentation performance, knowledge is 
lacking of phenotype variation among respiration-deficient mutants and specific genetic targets 
for maximizing ethanol production with minimal impact on growth phenotype.  There are 
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numerous approaches (genetic or chemical) to generate respiration-deficient mutants of S. 
cerevisiae, and all of the resulting strains are not equivalent.  For example, some respiration-
deficient mutants may have better fermentation performance than others, as illustrated by the 
large variation in ethanol production among 20 knockout strains identified and screened in this 
study (Fig. 2.2).  Also, many respiration-deficient mutants are accompanied by a significant 
penalty in terms of cell growth, but the growth defect may be quite different among these strains 
(Fig. 2.2).  In this study, the model-based gene deletion simulation indicated that COX-related or 
QCR-related deletion targets are better than other components of the respiratory system (e.g. 
NADH dehydrogenase, succinate dehydrogenase, fumarase, etc.) for improving ethanol 
production and maintaining sufficient biomass production.  By experimental screening of the 
COX- and QCR-related mutants, we identified three specific knockout strains with maximum 
ethanol production and little or no growth penalty (∆cox9, ∆qcr6, and ∆qcr9).  Previously, it was 
reported that COX9 exists as a single copy in haploid strains of S. cerevisiae, produces one major 
transcript, and encodes subunit VIIa of the COX enzyme complex, which is essential for 
respiratory function (Wright et al., 1986).  Similarly, QCR9p, the smallest subunit of the QCR 
complex, is critical for correct structure of the enzyme and thus necessary for respiratory growth; 
its deletion led to elimination of electron transfer activity at the ubiquinol oxidase site (Graham 
et al., 1992; Phillips et al., 1990).  In another study, QCR6p was demonstrated necessary for 
activity of the QCR complex only at high temperature (37°C), but the deletion mutant showed 
normal respiratory growth at 30°C (Yang and Trumpower, 1994).  The present study is the first 
to describe the ∆cox9, ∆qcr6, and ∆qcr9 strains in terms of ethanol-producing capability and to 
demonstrate the superlative characteristics of these three knockout mutants among many others 
for improving hexose fermentation in S. cerevisiae under microaerobic conditions.  The ∆qcr6 
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mutant was particularly interesting with a 24% improvement in ethanol production rate and no 
growth defect.  Future work will be needed for elucidating the molecular mechanism to explain 
why eliminating specific protein subunits (Qcr6p, Qcr9p, or Cox9p) from the QCR or COX 
enzyme complex has a more beneficial influence on ethanol production and biomass yield than 
removing other subunits or related proteins. 
We have demonstrated that the benefits of deleting COX9, QCR6, or QCR9 in S. 
cerevisiae for ethanol production in limited-oxygen conditions are consistently observed in 
different strain backgrounds and extend to common hexoses such as glucose, fructose, mannose, 
or sucrose (Fig. 2.4).  Even the industrial strain fermentation with high initial glucose 
concentration showed an increase in average ethanol production rate and glucose consumption 
rate by the knockout strains tested; however, it is also important to note that improvements were 
significantly reduced in these highly fermentative conditions (Fig. 2.6).  We admit that extreme 
sugar concentration or strict anaerobic conditions will lessen the beneficial effects by the 
knockout strains described in this study.  It is well known that excess glucose represses 
respiration and contributes to highly fermentative metabolism in S. cerevisiae even in the 
presence of oxygen (i.e. Crabtree effect).  Also, strict anaerobic conditions will certainly 
minimize respiration and maximize fermentation by yeast.  In these situations, S. cerevisiae 
performs fermentation very well, and there is often little or no room for improvement by 
metabolic engineering.  Still, some advantage could come from engineering strains that assure 
optimal fermentation in various conditions and does so regardless of changing process 
parameters such as dissolved oxygen or sugar concentration.  For example, some applications 
may benefit from improved fermentation at lower sugar concentrations under continuous culture 
conditions.  Also, many large-scale fermentations do not begin with a strict anaerobic 
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environment (i.e. no reactor purging, no nitrogen charging, no tight sealing of the vessel).  Thus, 
the fermentation will behave anaerobically only after all initial dissolved oxygen is consumed by 
the cells, which means that substantial process time in a microaerobic state is possible.  In 
changing or non-ideal fermentation conditions, the ∆qcr6 mutant may offer particular advantages 
due to faster ethanol production rate, higher yield, and no biomass penalty.   
In conclusion, we emphasize that the main significance of the present study lies in the 
methodology used.  The single knockout strains described in this work are quite beneficial in 
certain conditions (microaerobic, lower external sugar concentration), but we cannot claim to 
have the best ever ethanol-producing S. cerevisiae strains.  Still, the combination of genome-
scale metabolic modelling with genetic screening using a systematic knockout collection could 
prove to be valuable in many other cases for reducing a large set of gene targets and identifying 
specific targets of interest.     
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2.5  Figures and tables 
 
Fig. 2.1 (a) The in silico ethanol and biomass specific productivity for the wild type strain and 
twenty knockout mutants and (b) the percent change in ethanol and biomass yield by gene 
deletion as a function of oxygen uptake rate. Symbols: wild-type ethanol (closed blue triangle), 
knockout ethanol (open blue triangle), wild-type biomass (closed green circle), and knockout 
biomass (open green circle). 
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Fig. 2.2 A total of (a) eighteen cytochrome c oxidase single knockout mutants and (b) nine 
cytochrome c reductase single knockout mutants were screened by glucose fermentation in 
minimal media. The average percent change in ethanol production rate and biomass yield is 
displayed for each knockout mutant as compared to control strain BY4742. All results are the 
average of duplicate experiments and the error bars represent one standard deviation. 
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Fig. 2.3 Fermentation profiles for glucose consumption and ethanol production during flask 
fermentation by S. cerevisiae strains: (a, b) BY4742 and BY4742 ∆cox9, (c, d) CEN.PK2-1D, 
CEN.PK2-1D ∆qcr6, and CEN.PK2-1D ∆qcr9.  All results are the average of duplicate 
experiments. The error bars represent one standard deviation and are not visible when smaller 
than the symbol size. 
 
 
 49 
 
 
Fig. 2.4 Comparison of (a) ethanol production rate, (b) ethanol yield, and (c) final cell density by 
laboratory strain BY4742 and knockout strains BY4742 ∆cox9, BY4742 ∆qcr6, and BY4742 
∆qcr9 during fermentation in minimal media with four different carbon sources: glucose, 
mannose, fructose, and sucrose. All results are the average of duplicate experiments and the error 
bars represent one standard deviation.  The student t test was used to establish significant 
differences between fermentations conducted with the knockout strains and the control strain.    
*, P < 0.05 (95% confidence). †, P < 0.10 (90% confidence). 
 
 
 
 
 50 
 
 
 
Fig. 2.4 (cont.) 
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Fig. 2.5 Wild-type S. cerevisiae with CEN.PK2-1D background or BY4742 background and 
single knockout mutants of cytochrome c oxidase (∆cox9) and cytochrome c reductase (∆qcr6, 
∆qcr9) were grown on YP glycerol agar plates.  Plates were incubated at 30°C for 3 days 
(CEN.PK2-1D) or 6 days (BY4742). 
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Fig. 2.6 Comparison of ethanol yield, ethanol production rate, and glucose consumption rate by 
industrial strain JAY291 and knockout strains JAY291 ∆qcr6 and JAY291 ∆qcr9 during 
fermentation in minimal media with high initial glucose concentration. All results are the average 
of duplicate experiments and the error bars represent one standard deviation.  The student t test 
was used to establish significant differences between fermentations conducted with the knockout 
strains and the control strain. *, P < 0.05 (95% confidence). †, P < 0.10 (90% confidence). 
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Table 2.1 Primers used in this study 
 
  
Primer Sequence Comment 
COX9-f AGTTTGTGGTTGAGCAGTCG COX9 deletion cassette 
using a KanMX marker COX9-r GGCAAATTGGCAGGTATTCG 
Cd-f CCTTCGATGGATTCGTCAGT confirm COX9 deletion  
KanMX-r CTTTTCCTTACCCATGGTTGT  
QCR6-f GCTACAATCAAGCCGCGGCTAT QCR6 deletion cassette 
using a KanMX marker QCR6-r CTACCTGCATTTCCAATGGGCG 
Q6d-f GGTGGAAGGTATGGATATGGA confirm QCR6 deletion 
QCR9-f GGGTGACGAATTTCGAGTGACT QCR9 deletion cassette 
using a KanMX marker QCR9-r GCAAAGACAACCCCAAACCCTA 
Q9d-f TGCCATGAGAAGAGGTGATTTA confirm QCR9 deletion 
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Table 2.2 In silico gene deletion targets for improving ethanol production while maintaining 
adequate biomass for cell growth 
Standard 
Name 
Systematic 
Name Enzyme Name Classification 
COX1 Q0045 
cytochrome c 
oxidase 
(complex IV) 
Oxidative 
Phosphorylation 
COX2 Q0250 
COX3 Q0275 
COX4 YGL187C 
COX6 YHR051W 
COX7 YMR256C 
COX8 YLR395C 
COX9 YDL067C 
COX12 YLR038C 
COX13 YGL191W 
COB Q0105 
ubiquinol 6 
cytochrome c 
reductase 
(complex III) 
COR1 YBL045C 
CYT1 YOR065W 
QCR2 YPR191W 
QCR6 YFR033C 
QCR7 YDR529C 
QCR8 YJL166W 
QCR9 YGR183C 
QCR10 YHR001W-A 
RIP1 YEL024W 
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Table 2.3 Fermentation parameters
a
 of S. cerevisiae wild type and ∆cox9, ∆qcr6, and ∆qcr9 
mutants in glucose with various strain backgrounds 
Strains 
 Glucose  
rGluc ± SD PEtOH ± SD YEtOH ± SD 
BY4742 0.811 ± 0.009 0.275 ± 0.002 0.339 ± 0.002 
BY4742 ∆cox9 0.991 ± 0.002 0.376 ± 0.003 0.380 ± 0.004 
BY4742 ∆qcr6 0.952 ± 0.006 0.342 ± 0.010 0.359 ± 0.009 
BY4742 ∆qcr9 0.959 ± 0.009 0.349 ± 0.007 0.364 ± 0.004 
CEN.PK2-1D 1.312 ± 0.004 0.448 ± 0.008 0.342 ± 0.006 
CEN.PK2-1D ∆cox9 1.586 ± 0.001 0.594 ± 0.006 0.375 ± 0.004 
CEN.PK2-1D ∆qcr6 1.573 ± 0.002 0.608 ± 0.002 0.387 ± 0.001 
CEN.PK2-1D ∆qcr9 1.567 ± 0.002 0.619 ± 0.003 0.395 ± 0.003 
 
a) 
Fermentation parameters were measured at 36.5 hrs (BY4742) or 22 hrs (CEN.PK2-1D) of incubation. rGluc, 
glucose consumption rate (g glucose/L∙hr); PEtoh, ethanol productivity (g ethanol/L∙hr); YEtoh, ethanol yield (g 
ethanol/g glucose); SD means standard deviation 
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3.1  Introduction 
Biological production of fuels and chemicals by native or engineered microorganisms has 
received much attention in recent years as a sustainable alternative to chemical synthesis from 
limited petroleum-derived hydrocarbons.  In order to become an economically viable option with 
significant environmental benefits, fuels and chemicals should be synthesized from renewable 
non-food plant sources, such as lignocellulosic biomass or marine plant biomass (Ragauskas et 
al., 2006).  These feedstocks are renewable, cheap, and abundant; however, they also contain 
significant portions of sugars that cannot be readily fermented by industrial microorganisms.  
Slow and inefficient conversion of nonfavored carbon sources by fermenting microorganisms is 
an intrinsic problem delaying the sustainable production of biofuels, biochemicals, and other 
biomaterials (Stephanopoulos, 2007).  The identification of novel gene targets for improving 
utilization of non-glucose sugars which are abundant in plant cell wall hydrolyzates is a critical 
aspect of industrial strain construction and has been a focus of numerous metabolic engineering 
studies.  
Galactose is the major sugar obtained from hydrolysis of some marine biomass, such as 
red seaweed (Yoon et al., 2010), and is also found in other industrial sources such as cheese 
whey (Siso, 1996) or molasses (Rosen, 1987).  The metabolic pathway for conversion of 
galactose to the glycolytic intermediate glucose-6-phosphate, called the Leloir pathway, is under 
strict genetic control and has long been of interest as a model system for studying gene 
expression and transcriptional control in eukaryotes (Timson, 2007).  The yeast Saccharomyces 
cerevisiae, which is a common microorganism for industrial biotechnology, possesses the 
complete Leloir pathway and is capable of growing on galactose, but the specific uptake rates are 
approximately 2.5-3.3-fold lower than those on glucose. Moreover, ethanol yield and 
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productivity are known to be considerably lower during galactose fermentation as compared to 
glucose fermentation because of slower respiro-fermentative metabolism caused by a lack of the 
Crabtree effect (Ostergaard et al., 2000e).  In previous studies, two distinct metabolic 
engineering approaches have been applied to improve galactose utilization by S. cerevisiae.  
Ostergaard et al. used a rational approach to achieve balanced overexpression of galactose 
metabolic genes by modifying the regulatory network of the Leloir pathway.  They found that 
deletion of three genes encoding negative regulators of GAL gene expression (GAL6, GAL80, 
and MIG1) led to a 41% increase in galactose uptake rate, and overexpression of one gene 
encoding a positive activator (GAL4) led to a 26% increase in uptake rate (Ostergaard et al., 
2000b).  However, the ad hoc pathway manipulation approach is limited because of the lack of 
rigorous system-wide analysis and thus potential for unknown or unexpected interactions 
between reactions or pathways.  Therefore, combinatorial approaches, which involve random 
genetic perturbations and appropriate screening or selection techniques, have proven to be more 
valuable for identifying novel genetic targets to improve galactose fermentation in yeast.  A 
particular advantage of combinatorial engineering is unique access to still poorly understood 
cellular subsystems, unknown regulatory genes, or non-coding regions that are critical for 
cellular function and could not be identified by a more rational approach (Alper, 2006; Sauer and 
Schlattner, 2004).  For example, Lee et al. employed a genome-wide perturbation library and 
careful selection techniques to engineer superior galactose-fermenting yeast strains, which led to 
discovery of overexpression targets SNR84 (encoding a small nuclear RNA) and truncated TUP1 
(encoding a general repressor of transcription) (Lee et al., 2011). Also, Hong et al. utilized an 
evolutionary engineering approach with a laboratory strain over many generations to increase 
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galactose uptake rate and growth rate; this led to identification of an unexpected mutation in 
RAS2 (encoding a GTP-binding protein) (Hong et al., 2011b). 
The aforementioned metabolic engineering studies have demonstrated the utility of 
rational or combinatorial approaches for improving galactose utilization by S. cerevisiaie, but the 
resulting engineered or evolved strains show enhanced galactose utilization only under aerobic 
conditions because of an inherent linkage between galactose metabolism and respiration (Hong 
et al., 2011b).  However, aerobic conditions are undesirable for the production of biofuels and 
chemicals because respiratory utilization of sugars can lead to lower yields (Zhang et al., 2010).  
Furthermore, it is not economical or convenient to maintain aeration during industrial-scale 
fermentation (Peng et al., 2012).  Thus, respiration-deficient yeast strains may be beneficial to 
ensure optimal fermentation in various conditions by eliminating oxidative metabolism of sugars 
and other fermentation products.  Respiration-deficient strains have been employed for 
improving ethanol productivity and/or yield by S. cerevisiae from glucose (Bacila and Horii, 
1979; Hutter and Oliver, 1998; Oner et al., 2005) or xylose (Jin et al., 2004; Peng et al., 2012).  
However, development of a respiration-deficient galactose-fermenting strain has not been 
attempted and is especially challenging because galactose metabolism is associated with 
heightened respiratory activity (Fendt and Sauer, 2010).  
In this study, we aimed to construct optimal yeast strains that maximize carbon flux from 
galactose through the fermentation pathway rather than the respiration pathway.  For this 
purpose, a respiration-deficient mutant was used for strain development; specifically, we 
employed a laboratory strain with deletion of COX9 (encoding a subunit of cytochrome c 
oxidase).  The BY4742 ∆cox9 mutant was shown to have higher fermentation rate and efficiency 
than the parental strain with only a minor growth disadvantage on glucose, fructose, sucrose, or 
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mannose.  However, this Cox9-negative strain was unable to grow with galactose as the sole 
carbon source.  Interestingly, we found that spontaneous genetic mutations during prolonged 
incubation allowed the respiration-deficient strain to use galactose fermentatively, and the best 
mutants were enriched by serial subculture.  As follows, we present the results of an integrated 
systems biology analysis of the evolved galactose-fermenting strains developed in this study.  
Furthermore, we describe a new paradigm for evolutionary engineering, termed “fermentative 
evolution,” whereby a metabolic “death valley” may be a beneficial intermediate step to provide 
pressure for adaptive evolution of microbial strains toward optimal production of ethanol or 
other fermentation products.   
 
3.2 Materials and methods 
 
3.2.1 Yeast strains and evolutionary engineering 
 S. cerevisiae strain BY4742 (MATalpha, leu2, his3, ura3, lys2) was used in this study as a 
control strain. Single knockout mutant BY4742 ∆cox9 was obtained from Yeast Knockout 
MATalpha Collection (OpenBiosystems, Lafayette, CO) and was the starting strain for adaptive 
evolution.  After almost 100 hours, the ∆cox9 mutant began to grow in galactose (40 g/L) 
minimal media and evolved mutants were generated by serial subculture over ≈15 generations. 
Two single colony isolates were obtained from the last shake flasks and named JQ-G1 and JQ-
G2.  All strains and plasmids used in this work are summarized in Table 3.1.  The primers used 
for amplification of gene deletion cassettes and mutant YHP1 insert for cloning are shown in 
Table 3.2, along with confirmation primers. 
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3.2.2 Medium and culture conditions 
 To prepare yeast strains for inoculation, cells were cultivated overnight at 30°C and 300 
RPM in YPD medium (10 g/L yeast extract, 20 g/L Bacto peptone, 20 g/L glucose).  Batch 
fermentation was carried out at 30°C and 100 RPM in yeast synthetic complete (SC) medium 
composed of 1.7 g/L yeast nitrogen base, 5 g/L ammonium sulfate, and 0.79 g/L CSM (MP 
Biomedicals, Solon, OH) for supplying amino acids and nucleobases.  Galactose (or other sugar) 
was added to provide the carbon source.  For anaerobic fermentations, ergosterol and Tween80 
were also included in the medium at a final concentration of 10 mg/L and 420 mg/L, 
respectively.  To select yeast transformants with an amino acid auxotrophic marker, a SC agar 
plate prepared with CSM-His-Leu-Ura (MP Biomedicals, Solon, OH) was used.  
 
3.2.3 Fermentation experiments 
 Yeast pre-cultures were grown with 5 mL of YPD medium in an orbital shaker at 30°C to 
prepare inoculums for fermentation experiments.  Cells in exponential phase were harvested and 
inoculated after removing used YPD.  Flask fermentation experiments were performed using 25 
mL (or 50 mL) of SC medium with 40 g/L of the appropriate sugar in a well-controlled shaking 
incubator (Thermoscientific, MaxQ4000, Dubuque, IA) under oxygen-limited conditions.  Initial 
cell densities were adjusted to OD600 of ~0.1 unless otherwise noted.  During the course of the 
fermentation, the temperature and agitation rate were kept constant at 30°C and 100 RPM, 
respectively.  Anaerobic fermentations were conducted in 20 mL of SC medium with the 
appropriate sugar in a sealed and purged 100 mL vial.   
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3.2.4 Analytical methods   
Cell growth was measured by optical density (OD) at 600 nm using a UV-visible 
spectrophotometer (Biomate 3, Thermoscientific, Madison, WI).  The concentration of 
extracellular metabolites was determined by a high-performance liquid chromatography system 
(Agilent Technologies 1200 series) with a Rezex ROA-Organic Acid H+ column (Phenomenex 
Inc., Torrance, CA).  Column temperature was kept constant at 50°C and the elution was 
performed with 0.005 N H2SO4 at a flow rate of 0.6 ml/min.  Galactose, ethanol, acetate, and 
glycerol were detected with a refractive index detector (RID) and oxaloacetate was detected with 
a diode-array detector (DAD) at 210 nm. 
 
3.2.5 Genome sequencing and SNP discovery 
 The genomic DNA of BY4742, BY4742 ∆cox9, and evolved strains JQ-G1 and JQ-G2 
was prepared with the YeaStar Genomic DNA Kit (Zymo Research, Irvine, CA) and quality was 
confirmed in a 1% agarose gel.  Sequencing (SE100) was done using an Illumina HiSeq2000 
machine at the W.M. Keck Center for Comparative and Functional Genomics at the University of 
Illinois at Urbana-Champaign.  The barcoded shotgun genomic DNA libraries were constructed 
with the TruSeq Sample Prep Kit (Illumina, San Diego, CA).  The raw data was processed with 
Casava 1.8.  Approximately 11,000,000 reads were obtained for each sample, which corresponds 
to >50X sequence coverage.  Variant analysis (either SNPs or INDELs) was performed using 
CLC Genomics Workbench version 7.0.4.  Reads were trimmed based on quality scores with 
default program settings and the trimmed reads were mapped to an S288C reference sequence 
(obtained from Genbank; accession numbers for 16 chromosomes and the mitochondrial 
genome: NC_001133 through NC_001148 and NC_001224) using the following settings: 
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Masking mode = No masking; Mismatch cost = 2; Insertion cost = 3; Deletion cost = 3; Length 
fraction  = 0.5; Similarity fraction = 0.8; Global alignment = No; Non-specific match handling = 
Ignore.  The BY4742, BY4742 ∆cox9, JQ-G1, and JQ-G2 SNPs or INDELs were identified 
using the probabilistic variant detection algorithm in CLC Genomics Workbench and the 
following settings:  Ignore non-specific matches = YES; Ignore broken pairs = Yes; Minimum 
coverage = 30; Variant probability = 90.0; Required variant count = 30; Require presence in both 
forward and reverse reads = No; Ignore variants in non-specific regions = Yes; Filter 454/Ion 
homopolymer indels = No; Maximum expected variants = 1.  Each strain yielded approximately 
150 variants compared to S288C.  The SNPs unique to JQ-G1 and JQ-G2 relative to BY4742 
∆cox9 were then determined by comparing the SNP files using the "Filter against Known 
Variants" function in CLC Genomics Workbench.  Of the 144 variants common to JQ-G1 and 
JQ-G2, only 9 variants were unique when compared to the parental strain BY4742 ∆cox9 (Table 
3.3). 
 
3.2.6 Metabolic flux analysis 
 The BY4742 and JQ-G1 strains were inoculated into defined minimal media as described 
previously (Christen and Sauer, 2011) with 10 g/L [1-13C] galactose (Cambridge Isotope 
Laboratories).  Cells were grown in duplicates and harvested during mid-exponential phase (Fig. 
3.10).  Hydrolysis of biomass, derivatization of amino acids, GC-MS analysis, measurement of 
isotope labeling patterns, and metabolic flux calculations were carried out as discussed 
thoroughly in a previous study (Feng and Zhao, 2013).  In general, extracellular fluxes were 
calculated from HPLC data using two samples from exponential growth phase.  A stoichiometric 
model developed by Feng and Zhao (Feng and Zhao, 2013) was modified to include the Leloir 
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pathway and used in this study to fit the metabolic flux data.  The stoichiometric reactions 
included in the metabolic model and the standard deviation of calculated fluxes is shown in Fig. 
3.11.  The measured and simulated isotopomer labeling patterns of amino acids are compared in 
Fig. 3.12.   
 
3.2.7 Metabolite profiling 
 The BY4742 and JQ-G1 strains were inoculated into defined minimal media as described 
previously (Christen and Sauer, 2011) with 10 g/L galactose.  Cells were grown in triplicates and 
harvested during mid-exponential phase (Fig. 3.10).  Quenching was done quickly in cold 
methanol (≤-40°C) with a 5:1 ratio of solvent to culture broth.  Metabolite extraction, 
derivatization, and GC-MS analysis were carried out as described previously (Kim et al., 2013b).  
For processing the GC-MS data, we used AMDIS software version 2.7.1 (Davies, 1998) for peak 
deconvolution and automatic detection and then uploaded the data to SpectConnect (Styczynski 
et al., 2007) for peak alignment and generating the data matrix.  The Golm Metabolome 
Database mass spectral reference library (Hummel et al., 2007) was used for metabolite 
identification. 
 
3.3 Results 
 
3.3.1 Physiological characterization of evolved mutants 
 While it has been known that galactose cannot be utilized by native S. cerevisiae strains 
under anaerobic conditions (i.e. without metabolic fluxes towards the respiratory pathway), we 
found that a respiration-deficient mutant (BY4742 ∆cox9) was able to grow and use galactose 
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fermentatively after serial subcultures in minimal media with galactose as the sole carbon source.  
The change in galactose uptake rate and ethanol yield during the serial subcultures was quite 
abrupt and dramatic (Fig 3.6a), with most of the phenotype improvement already observed in the 
second subculture.  Two evolved strains, JQ-G1 and JQ-G2, were isolated from the last shake 
flask after enrichment over a relatively short period of time (≈6 days).  The evolved strains not 
only consumed galactose faster than the wild-type (2.5-fold improvement) but also were far 
superior in terms of ethanol yield (1.9-fold improvement) and volumetric productivity (4.8-fold 
improvement).  As expected, the phenotype advantages of the evolved strain were accompanied 
by a 20% reduction in biomass production.  Fig. 3.1 shows the complete fermentation profile on 
galactose by wild-type BY4742 (a), knockout BY4742 ∆cox9 (b), and evolved knockout JQ-G1 
(c).  The intermediate step of COX9 deletion between the parental strain and evolved strains 
strongly inhibited galactose utilization, but the deletion was also crucial for achieving optimal 
galactose fermentation rapidly through adaptive evolution.  In contrast, serial subculture with the 
respiration-competent wild-type strain resulted in relatively little increase in galactose uptake 
rate or ethanol yield during the same time period required to generate our respiration-deficient 
evolved strains (JQ-G1 and JQ-G2).  Also, it is noteworthy that COX9 deletion offered a great 
advantage for enhancing galactose utilization in a condition where the deletion greatly inhibited 
growth, but serial subculture of the ∆cox9 mutant with fructose or mannose as the sole carbon 
source did not lead to improvement in sugar consumption or ethanol production (Fig. 3.6b-c).  
As reported previously, BY4742 ∆cox9 grows well in minimal media with fructose or mannose 
and produces ethanol even better than the parental strain. 
To evaluate stability of the galactose-evolved mutant phenotype, JQ-G1 and JQ-G2 were 
grown in minimal media with glucose for an extended period (3 serial subcultures or ≈15 
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generations) and then immediately transferred to galactose minimal media.  The extended growth 
in glucose did not have any significant effect on galactose uptake rate, ethanol yield or ethanol 
productivity by the evolved strains (P > 0.05).  Also, we tested detailed metabolic phenotype of 
the evolved strains on other hexoses. When growing the galactose-evolved mutant on glucose, 
we observed that JQ-G1 produced 22% more ethanol and consumed glucose 21% faster than the 
wild-type (BY4742), although with an 8% reduction in biomass production.  Similar results were 
observed during fermentation experiments with mannose, fructose, or sucrose as the sole carbon 
source, except that the JQ-G1 strain did not show a significant reduction in biomass production 
on the latter two sugars as compared to the wild-type (P > 0.05).  Fig 3.2 shows the specific 
sugar uptake rate (a) and specific ethanol production rate (b) by JQ-G1 versus BY4742 on all 
sugars evaluated.  For each of the five carbon sources, the evolved strain showed significant 
improvement in sugar uptake rate and ethanol productivity (P < 0.05), with the largest 
advantages on galactose and the smallest advantage on sucrose. 
The previous fermentations were performed with fairly low initial cell density (0.03 g/L), 
but we wanted to get an idea of the fermentation parameters of the evolved strain with a larger 
inoculum.  By increasing initial cell density to ~1.5 g/L, we were able to improve galactose 
uptake rate and ethanol productivity by JQ-G1 in minimal media to 1.84 g/L∙hr and 0.68 g/L∙hr, 
respectively, as compared to 1.01 g/L∙hr and 0.34 g/L∙hr by BY4742.  In these conditions, JQ-G1 
grew as well as, or slightly better than, the wild-type strain and also generated about one-fourth 
the acetate.  Ethanol yield by the evolved strain was similar in the low cell density (0.38 g/g) and 
high cell density (0.37 g/g) fermentations.  Fig. 3.7 shows the fermentation profile of these 
strains in the high cell density experiment.  
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3.3.2 Changes in genotype and reverse engineering of galactose-fermenting strains 
 The entire genome of the evolved mutants JQ-G1 and JQ-G2, as well as control strains 
BY4742 and BY4742 ∆cox9, was sequenced and compared in order to identify genetic 
perturbations associated with improved galactose metabolism without respiration.  Any SNPs 
observed in the evolved strains but not present in either control strain are real and may contribute 
to the beneficial phenotype.  After eliminating silent substitutions or genetic mutations in non-
coding regions, there were only two remaining SNPs shared in both evolved strains: a truncation 
in GAL80 (Glu348*) and a point mutation in YHP1 (Glu67Gln).  GAL80 is known to be a 
transcriptional repressor involved in repression of GAL genes (Johnston, 1987).  YHP1 is another 
transcriptional repressor encoding a homeoprotein (Kunoh et al., 2000), but this gene has not 
been reported to be linked with galactose metabolism. 
 Initially, we hypothesized that the observed mutations in GAL80 and YHP1 might cause 
loss of function of the related genes in evolved strain JQ-G1.  In order to test the effect of these 
deletions, we constructed single knockout strains BY4742 ∆gal80 and BY4742 ∆yhp1, as well as 
double and triple knockout strains with deletion of every possible combination of GAL80, YHP1, 
and COX9 (since the evolved strains are COX9-negative).  The knockout strains were evaluated 
in minimal media with 40 g/L of galactose, and then specific sugar uptake rate and specific 
ethanol production rate were calculated for each mutant (Fig. 3.3).  First, the results clearly 
indicate the negative impact of transcriptional repressor GAL80p on galactose fermentation 
parameters, as deletion of the associated gene (GAL80) increased specific galactose uptake rate 
and specific ethanol production rate in the wild-type strain by a factor of 1.6 and 2.3, 
respectively.  The BY4742 ∆gal80 mutant had a shorter lag time on galactose and grew faster 
than the control during the early part of the fermentation, but final cell density was similar for 
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both strains.  Furthermore, deletion of GAL80 in a respiration-deficient strain (BY4742 ∆cox9) 
had an even more drastically positive effect on galactose fermentation, resulting in a double 
knockout mutant with 5.4-fold improvement in specific ethanol productivity over the wild-type 
and a similar ethanol yield as JQ-G1 (0.389 ± 0.008 g/g versus 0.384 ± 0.003 g/g, respectively).  
The BY4742 ∆cox9 ∆gal80 strain was better than all other knockout strains in this study in terms 
of galactose fermentation rate and efficiency, although specific ethanol production rate was still 
19% lower than that of evolved strain JQ-G1.  Not surprisingly, the ∆cox9 ∆gal80 mutant also 
had a longer lag time and generated 27% less biomass than the wild-type strain.  Second, the 
results demonstrate that YHP1 deletion did not have a significant effect on growth or other 
galactose fermentation parameters in any of the strains tested.  Also, expression of mutant YHP1 
(Glu67Gln) on a single-copy plasmid in BY4742 ∆cox9 ∆gal80 ∆yhp1 resulted in very marginal 
improvement in ethanol yield as compared to a control strain harboring the null vector (Fig. 3.8).  
Third, our results show that COX9 deletion was beneficial in all GAL80-negative strains for 
increasing ethanol yield and productivity from galactose, but the same deletion (∆cox9) was 
inhibitory for growth and fermentation in the GAL80-positive strains.  To confirm the effect of 
deleting COX9 in the evolved strain, we introduced a COX9 cassette into the JQ-G1 strain and 
selected transformants on a glycerol plate.  The JQ-G1-COX9 strain showed a 33% reduction in 
specific galactose uptake rate and a 49% reduction in specific ethanol production rate as 
compared to JQ-G1, although the COX9-expressing strain had a shorter lag time.  Table 3.4 
provides a summary of important fermentation parameters for engineered strains in this study.   
  
3.3.3 Integration of fluxomic and metabolomic data  
In order to elucidate metabolic changes related to efficient galactose fermentation by a 
respiration-deficient strain, we sought quantification of metabolic flux and metabolite abundance 
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in the evolved strain as compared to the wild-type strain.  Extracellular fluxes and isotope 
labeling patterns of proteinogenic amino acids were used to calculate the distribution of 
intracellular metabolic fluxes in the wild-type and evolved strains during steady-state growth on 
[1-
13
C] galactose (Fig. 3.4).  The galactose uptake fluxes were normalized to a relative value of 
100 in both strains.  Based on the 
13
C-MFA results, the BY4742 and JQ-G1 strains were similar 
in that glycolysis was the main catabolic pathway for break-down of glucose-6-phosphate 
generated by the Leloir pathway.  In both strains, at least 95% of carbon flux was processed by 
glycolysis (relative flux value of 94.5 – 97.7) and thus only a small percentage was shuttled 
toward the pentose phosphate pathway (relative flux value of 2.9 – 5.3).  After glycolysis, the 
metabolic fluxes split at the node of pyruvate to enter either the ethanol fermentation pathway or 
the TCA cycle.  Comparison of TCA cycle fluxes in the two strains revealed major differences, 
with the evolved strain demonstrating almost 3-fold reduction as compared to the wild-type 
(relative flux value of 23.4 versus 63.6).  The higher TCA cycle flux in the parental strain is 
consistent with previous studies that have shown the importance of oxygen supply and high 
cellular energy charge for galactose metabolism (Sanchez et al., 2010a; van den Brink et al., 
2009).  However, results in the current study demonstrate that much of the excess TCA cycle 
flux has been redirected to the ethanol fermentation pathway in evolved strain JQ-G1, while still 
maintaining enough ATP and biomass precursors for cell growth.  Almost 73% of total pyruvate 
flux was converted to ethanol in the evolved strain, while only about 52% of pyruvate flux 
passed through the two-step fermentation pathway in the wild-type strain.  Conversely, much 
less of the pyruvate flux was directed to acetyl-CoA by the evolved strain as compared to the 
wild-type, either in the cytosol (relative flux value of 8.1 versus 38.4) or the mitochondria 
(relative flux value of 2.0 versus 6.6).  The futile cycle including pyruvate carboxylase and 
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phosphoenolpyruvate carboxykinase was active in both strains but with similar flux values.  
Differences between the calculated flux results in this study and two previous 
13
C-MFA studies 
with S. cerevisiae growing on galactose may be due to the use of different strain backgrounds: 
CEN.PK 113-7D by Ostergaard et al. (Ostergaard et al., 2001), FY4 by Fendt and Sauer (Fendt 
and Sauer, 2010), and BY4742 in this study.  The host dependence could lead to large variations 
in metabolic flux, as was found in pathway switch experiments for xylose utilization (Feng and 
Zhao, 2013). 
To further investigate the metabolic flux distributions during growth of evolved strain 
JQ-G1 on galactose and to identify potential rate-limiting reactions in central carbon metabolism, 
we also measured intracellular metabolite concentrations by GC-MS analysis.  The results 
showed 38 metabolites whose intracellular concentration was significantly changed (P < 0.05) in 
the evolved mutant as compared to the control strain (Fig. 3.5).  Pyruvate, a central node for 
many high flux metabolic pathways, had a higher concentration in the evolved strain, and this 
result matches the 
13
C-MFA data showing higher fermentation pathway flux from pyruvate to 
ethanol in this strain.  Also, it was not surprising that some TCA cycle intermediates, such as 
fumurate and malate, had a lower concentration in the JQ-G1 strain since its TCA cycle fluxes 
were also significantly lower than the control strain.  However, citrate, which is a longer six-
carbon intermediate early in the TCA cycle, was an exception in terms of the TCA cycle 
metabolites and had a higher concentration in the JQ-G1 strain. In general, the level of free 
amino acids was higher in the evolved strain, with aspartate and glutamate as the only individual 
amino acids not consistent with that trend.  Interestingly, the evolved strain had reduced levels of 
galactitol, which has been shown to play a role in galactose-induced toxicity (de Jongh et al., 
2008).  Finally, two other interesting metabolites, trehalose and glyceric acid-3-phosphate, had 
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reduced concentrations in the evolved strain and were included in Fig. 3.5, although the 
difference was not quite significant at the 95% confidence interval (P = 0.057 and P = 0.075, 
respectively).  In summary, the evolved mutant showed a clear separation from the control in the 
concentration of many key intracellular metabolites, such as amino acids, TCA cycle 
intermediates, and galactitol.   
 
3.4 Discussion 
Due to the limitations of rational metabolic engineering approaches (Çakar et al., 2012), 
evolutionary engineering has been widely used as a combinatorial tool in order to identify 
unknown or unexpected genetic targets for S. cerevisiae strain improvement.  The approach 
depends on some spontaneous or induced mutations in a starting strain and appropriate selection 
pressure for enriching fitter variants during serial or prolonged cultivation in liquid or solid 
media (Çakar et al., 2012; Sauer, 2001).  In numerous studies, evolutionary engineering has been 
used to improve strain performance by growing a sub-optimal wild-type microorganism in 
aerobic conditions for many generations.  While this conventional approach is perfectly suited to 
select for improved strains in the context of sugar consumption or cell growth, it is more 
challenging to find suitable selective conditions for evolved strains with maximum product 
formation.  Genetic mutations leading to faster growth by the host strain are important for out-
competing rival mutants and thus are selected for; however, these mutations may not result in the 
best product yield or production rate.  On the other hand, mutations leading to better product 
formation are usually not critical to the strain’s survival or performance, and therefore those 
mutants may not be enriched.  To overcome these challenges, we demonstrated that a metabolic 
“death valley” involving some stress or adverse genetic perturbations may be advantageous to 
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increase the rate of spontaneous mutagenesis in a population and provide pressure for rapid 
evolution toward a more desirable phenotype.  Though somewhat counterintuitive, we developed 
an efficient galactose-fermenting mutant by employing a starting strain with a mutation (∆cox9) 
that was detrimental to growth on galactose (i.e. a metabolic “death valley”).  The respiration 
deficiency of the starting strain had two very positive effects for evolutionary engineering: (i) 
forcing the cells to evolve quickly in order to survive in galactose minimal media, and (ii) 
redirecting metabolic flux toward the fermentation pathway to improve product yield (rather than 
directing flux toward respiratory metabolism).  The entire adaptive evolution process required 
only about 15 generations (≈6 days) and resulted in evolved strain JQ-G1 with a 590% 
improvement in specific ethanol productivity as compared to BY4742.  In contrast, Hong et al. 
evolved a wild-type strain of yeast for a much longer time period (400 generations or ≈62 days) 
and increased specific ethanol production rate by about 170% in the best evolved mutant 62C 
(Hong et al., 2011b).  Furthermore, adaptive evolution led to some evolutionary trade-offs when 
comparing the performance of 62C in glucose and galactose (Hong and Nielsen, 2013).  
However, mutations for aiding galactose fermentation by evolved strain JQ-G1 did not have a 
negative effect when fermenting glucose or other hexoses (Fig. 3.2).  Based on the results in this 
study, we suggest that our fermentative evolution approach offers an alternative to conventional 
evolutionary engineering and may be advantageous for maximizing production of ethanol or 
other fermentation products in a host strain.   
A previous study by Fendt and Sauer reported that several TCA cycle and electron 
transport chain enzymes were significantly up-regulated in S. cerevisiae during growth on 
galactose. Similarly, 
13
C-MFA calculations showed a heightened TCA cycle flux by the wild-
type yeast strain during growth on galactose as compared to glucose (Fendt and Sauer, 2010).  
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The importance of respiratory metabolism for galactose utilization was further demonstrated by 
the inability of respiration-deficient mutant ∆rip1 to consume galactose in aerobic substrate-
switch experiments due to low energy charge (van den Brink et al., 2009).  In the present study, 
we also observed no growth by respiration-deficient mutant ∆cox9 during batch fermentation in 
galactose minimal media.  Although heightened respiration is generally associated with galactose 
utilization, this mode of metabolism is certainly not ideal for attaining optimal conversion of 
galactose to ethanol or other fermentation products as discussed previously.  In this study, we 
demonstrated the possibility of efficient galactose utilization without respiration by deletion of 
COX9, encoding an electron transport chain enzyme subunit, and adaptive evolution, which led 
to a loss of function mutation in a negative regulator of the Leloir pathway (Gal80p).  The 
metabolic flux results clearly demonstrate the shift in carbon flux from the TCA cycle to the 
ethanol fermentation pathway in the evolved strain JQ-G1 (Fig. 3.4).  Also, re-introduction of a 
COX9 cassette back into the evolved strain significantly reduced its galactose fermentation 
performance in terms of sugar uptake rate and ethanol production (Fig. 3.3; Table 3.4); this result 
shows the value of inhibiting respiration for optimizing fermentation pathway flux from 
galactose (with some minor penalty in terms of cell growth).  Although Gal80p has been known 
to strongly inhibit galactose utilization in yeast (Ostergaard et al., 2000b), we demonstrate here 
the synergy between inhibition of respiration and elimination of Gal80p function for attaining 
high fermentation rate and yield from galactose.  Specifically, we reported that double knockout 
mutant ∆cox9∆gal80 significantly out-performed single knockout strain ∆gal80 in galactose 
minimal media under microaerobic conditions (Fig. 3.3; Table 3.4).  When respiration was 
inhibited by anaerobic conditions, deletion of GAL80 alone was sufficient for rapid and efficient 
galactose fermentation with no additional improvements by COX9 deletion (Fig. 3.9).   
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To our knowledge, this is the first study demonstrating efficient galactose fermentation 
by respiration-deficient S. cerevisiae.  The evolved strain JQ-G1, which was obtained through 
both systematic and combinatorial engineering, was quite impressive when compared to other 
galactose fermentation results by engineered yeast in the literature, although a laboratory strain 
background and minimal media conditions were used in this study.  We expect that key 
fermentation parameters can be further improved by employing an industrial strain as a host and 
optimizing process conditions.  The utility of the evolved strain could be extended to produce 
other fermentation products such as lactic acid or 2,3-butanediol from galactose by introducing 
the required pathways with additional metabolic engineering.  The point mutation in YHP1, 
which was identified by genome sequencing, did not have a significant effect on the phenotype 
of the evolved strain.  We could not completely reproduce the phenotype of JQ-G1 by reverse 
engineering (although the BY4742 ∆cox9 ∆gal80 double knockout strain was quite similar) so 
additional work will be needed to determine other genetic or epigenetic factors that may play a 
role in this strain.     
 
3.5  Figures and tables 
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Fig. 3.1 Strategy for fermentative evolution involves systematic deletion of a respiratory enzyme 
subunit and subsequent evolution of the respiration-deficient knockout strain by serial subculture 
in selective conditions. The strategy was applied for engineering S. cerevisiae towards optimal 
galactose fermentation. Galactose fermentation profiles by the wild-type strain BY4742 (a), 
knockout strain BY4742 ∆cox9 (b), and evolved knockout strain JQ-G1 (c). Symbols: galactose 
(blue triangle), ethanol (red square), cell growth (open circle), glycerol (orange diamond), and 
acetate (green triangle).  
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Fig. 3.2 Fermentation physiology of the evolved mutant strain JQ-G1 compared with reference 
BY4742 in glucose, fructose, mannose, sucrose, and galactose.  The data are shown as: (a) 
specific sugar uptake rate (mmol/g DW/hr) and (b) specific ethanol production rate (mmol/g 
DW/hr). *, P < 0.05. 
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Fig. 3.3 Plot of specific ethanol production rate versus specific galactose uptake rate for evolved 
mutant strain JQ-G1 (light green) compared with the parental strain BY4742 (dark blue) and all 
engineered strains prepared in this study – BY4742 ∆cox9 (red), BY4742 ∆yhp1 (light blue), 
BY4742 ∆gal80 (dark green), BY4742 ∆gal80∆yhp1 (brown), BY4742 ∆cox9∆gal80 (orange), 
BY4742 ∆cox9∆gal80∆yhp1 (purple), and JQ-G1 with re-integration of COX9 (yellow).  Dashed 
red arrows indicate steps for fermentative evolution. 
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Fig. 3.4 Metabolic flux calculation by 
13
C-based flux analysis approach for BY4742 (blue) and 
JQ-G1 (red) strains during exponential growth on galactose. The galactose uptake flux is 
normalized to 100 units for both wild-type and mutant strains.  The green arrows indicate 
metabolites that are used for cell growth in the biomass equation.  
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Fig. 3.5 Intracellular metabolite profile from wild-type strain BY4742 and mutant strain JQ-G1 
during exponential growth on galactose in triplicates. Red color indicates higher metabolite 
concentration and green color indicates lower metabolite concentration as compared to the 
average across all samples.   
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Fig. 3.6 Evolution of the BY4742 ∆cox9 strain by serial subculture on various carbon sources. 
Changes in the ethanol yield (blue) and sugar uptake rate (green) are shown during enrichment 
on galactose (a), fructose (b), or mannose (c).  Fermentation parameters were calculated at 
approximately 48 hrs (galactose) or 43 hrs (fructose and mannose) from inoculation in fresh 
media.  All subcultures were performed in oxygen-limited conditions (100 rpm) with minimal 
media and 40 g/L sugar. The initial cell density was adjusted to 0.03 g/L. For comparison, the 
fermentation performance of the parental strain BY4742 is shown at the left of each graph under 
similar conditions. 
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Fig. 3.6 (cont.) 
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Fig. 3.7 High initial cell density (OD600 = 5) fermentation by parental strain BY4742 (a) and 
evolved strain JQ-G1 (b) in minimal media with 40 g/L galactose. 
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Fig. 3.8 Effect of mutant YHP1 on galactose fermentation by S. cerevisiae. (a) Strategy for 
evaluating effect of mutant YHP1 from evolved JQ-G1.  Plasmids were sequenced after 
construction to confirm presence of point mutation (199G>C) in pRS413-mYHP1. (b) Ethanol 
yield (g/g) during flask fermentation by engineered S. cerevisiae strain BY4742 
∆cox9∆gal80∆yhp1 expressing one of the following: (i) empty vector pRS413, (ii) pRS413 with 
wild-type YHP1 insert, or (iii) pRS413 with mutant YHP1 insert from JQ-G1.  Results are the 
average of three biological replicates. 
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Fig. 3.9 Results of anaerobic galactose fermentation by wild-type strain BY4742, knockout 
strains BY4742 ∆gal80 and BY4742 ∆cox9∆gal80, and evolved strain JQ-G1.  Cells were 
inoculated at initial OD=1 into a sealed 100 ml vial containing 20 ml SC medium and 40 g/L 
galactose as the sole carbon source.  The vials were purged with nitrogen and incubated at 30°C 
and 100 rpm.  After 27 hours cultivation, samples of the culture broth were taken for HPLC 
analysis and measurement of cell growth.  Bars show consumed galactose and ethanol 
production (a) and glycerol production and final cell density (b) for all strains. 
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Fig. 3.10 Fermentation profiles for BY4742 (blue diamonds) and JQ-G1 (red triangles) in 
minimal media with 10 g/L galactose and very low initial cell density (OD600 ~ 0.03).  For both 
metabolite profiling and 
13
C-metabolic flux analysis experiments, cells were grown in these 
conditions and harvested during mid-exponential phase.  Data is shown for: (a) galactose 
consumption, (b) ethanol production, and (c) cell growth.  
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Fig. 3.10 (cont.) 
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Fig. 3.11 Metabolic flux calculation by 
13
C-MFA and the standard deviation associated with each 
flux value. The galactose uptake flux is normalized to 100 units for both wild-type and mutant 
strains. 
  
Reaction Flux SD Flux SD
Galactose(abcdef)+ATP===>G6P(abcdef) 100 0 100 0
G6P(abcdef)<==>F6P(abcdef) 96.8 1 94.5 0.5
F6P(abcdef)+ATP<==>FBP(abcdef) 97.7 0.2 95.2 0.2
FBP(abcdef)<==>DHAP(cba)+GAP(def) 97.7 0.2 95.2 0.2
DHAP(abc)<==>GAP(abc) 97.7 0.2 95.2 0.2
GAP(abc)<==>G3PG(abc)+ATP+NADH 195.5 0.3 190.5 0.4
G3PG(abc)<==>PEP(abc) 186.9 0.4 168 0.4
PEP(abc)<==>Pyr_cyt(abc)+ATP 198.1 0.6 184.6 1.5
G6P(abcdef)===>G6pg(abcdef)+NADPH 2.9 0.4 5.3 0.2
G6pg(abcdef)===>Ru5P(bcdef)+CO2(a)+NADPH 2.9 0.4 5.3 0.2
X5P(abcde)<==>Ru5P(abcde) -0.9 0.5 -0.6 0.3
Ru5P(abcde)<==>R5P(abcde) 2 0.3 4.7 0.2
X5P(abcde)+R5P(fghij)<==>S7P(abfghij)+GAP(cde) 0.7 0.2 0.5 0.1
X5P(abghi)+E4P(cdef)<==>F6P(abcdef)+GAP(ghi) 0.2 0.2 0.2 0.1
S7P(abcdefg)+GAP(hij)<==>E4P(defg)+F6P(abchij) 0.7 0.2 0.5 0.1
Pyr_cyt(abc)+CO2(d)+ATP<==>OAA_cyt(abcd) 23 0.8 23.4 1.8
Pyr_cyt(abc)===>ACCOA_cyt(bc)+CO2(a)+NADH 38.4 1.2 8.1 1
OAA_cyt(abcd)+ATP<==>PEP(abc)+CO2(d) 11.8 0.5 16.9 1.7
Pyr_cyt(abc)<==>Pyr_mit(abc) 6.5 0.5 0.6 0.4
OAA_cyt(abcd)<==>OAA_mit(abcd) 0.8 0.5 2.9 0.3
ACCOA_cyt(ab)<==>ACCOA_mit(ab) 57.1 1.3 21.6 0.5
Pyr_mit(abc)===>ACCOA_mit(bc)+CO2(a)+NADH 6.6 0.5 2 0.5
BY4742 JQ-G1
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Fig. 3.11 (cont.) 
  
Reaction Flux SD Flux SD
OAA_mit(abcd)+ACCOA_mit(ef)===>Cit_mit(dcbfea) 63.7 0.9 23.6 0.3
Cit_mit(abcdef)<==>ICIT_mit(abcdef) 63.7 0.9 23.6 0.3
ICIT_mit(abcdef)<==>AKG_mit(abcde)+CO2(f)+NADPH 63.7 0.9 23.6 0.3
AKG_mit(abcde)===>SucCoA_mit(bcde)+CO2(a)+NADH 63.6 1 23.4 0.3
SucCoA_mit(abcd)<==>Suc_mit([0.5]abcd+[0.5]dcba)+ATP 63.6 1 23.4 0.3
Suc_mit([0.5]abcd+[0.5]dcba)<==>Fum_mit([0.5]abcd+[0.5]dcba)+FADH2 63.6 1 23.4 0.3
Fum_mit([0.5]abcd+[0.5]dcba)<==>Mal_mit(abcd) 63.6 1 23.4 0.3
Mal_mit(abcd)<==>OAA_mit(abcd)+NADH 62.9 1.4 20.7 0.5
Mal_mit(abcd)<==>Pyr_mit(abc)+CO2(d)+NADPH 0.7 0.5 2.7 0.3
Pyr_cyt(abc)===>Acetaldehyde(bc)+CO2(a) 130.2 0.4 152.5 1.3
Acetaldehyde(ab)+NADH===>EtOH(ab) 102 0 134.9 0
Acetaldehyde(ab)===>Acetate(ab)+NADPH 28.2 0.4 17.6 1.3
Acetate(ab)+[2.0]ATP===>ACCOA_cyt(ab) 18.7 0.4 13.5 1.3
G3PG(abc)+NADH===>Glycerol(abc) 4.4 0 21.8 0
EtOH(ab)===>EtOH_ext(ab) 102 0 134.9 0
Acetate(ab)===>Acetate_ext(ab) 9.5 0 4 0
Glycerol(abc)===>Glycerol_ext(abc) 4.4 0 21.8 0
R5P(abcde)+C1(f)===>His(edcbaf) 1.3 0.2 4.2 0.5
PEP(abc)+PEP(def)+E4P(ghij)===>Phe(abcefghij) 0.5 0 0.3 0
AKG_mit(abcde)===>Glu(abcde) 0.1 0 0.1 0.1
OAA_cyt(abcd)===>Asp(abcd) 0.5 0.1 0.2 0
G3PG(abc)===>Ser(abc)+NADH 4.3 0.2 0.7 0.3
Ser(abc)+NADH<==>GLY(ab)+C1(c) 3.9 0.2 0.4 0.3
GLY(ab)<==>C1(b)+CO2(a)+NADH 3.1 0.2 -0.3 0.3
Pyr_mit(abc)===>Ala(abc) 0.4 0.1 0.5 0.1
Pyr_mit(abc)+Pyr_mit(def)+NADPH===>Val(abcef) 0.3 0.1 0.9 0.1
OAA_cyt(abcd)===>OAA_ext(ab) 9.8 0 3.5 0
BY4742 JQ-G1
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Fig. 3.12 Measured and simulated isotopomer labeling patterns of protein-bound amino acids in 
wild-type strain BY4742 (a) and evolved strain JQ-G1 (b) during exponential growth on 
galactose. 
 
 
 90 
 
Table 3.1 Strains and plasmids used in this study. 
 
Strain or plasmid Description 
Strains  
BY4742 MATalpha, ura3, his3, leu2, lys2 
BY4742 ∆yhp1 BY4742 ∆yhp1::LEU2 
BY4742 ∆cox9 BY4742 ∆cox9::KanMX4 
BY4742 ∆gal80 BY4742 ∆gal80::URA3 
BY4742 ∆gal80∆yhp1 BY4742 ∆gal80::URA3 ∆yhp1::LEU2 
BY4742 ∆cox9∆gal80 BY4742 ∆cox9::KanMX4 ∆gal80::URA3 
BY4742 ∆cox9∆gal80∆yhp1 BY4742 ∆cox9::KanMX4 ∆gal80::URA3 ∆yhp1::LEU2 
JQ-G1 BY4742 ∆cox9 evolved 
JQ-G1-COX9 JQ-G1 cox9::COX9 
B-CGY control BY4742 ∆cox9∆gal80∆yhp1 pRS413 
B-CGY-YHP1 BY4742 ∆cox9∆gal80∆yhp1 pRS413-YHP1 
B-CGY-mYHP1 BY4742 ∆cox9∆gal80∆yhp1 pRS413mYHP1 
  
Plasmids  
pRS413 HIS3 marker, a single copy plasmid 
pRS413-YHP1 Wild-type YHP1 inserted in pRS413 
pRS413-mYHP1 Mutant YHP1 from JQ-G1 inserted in pRS413 
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Table 3.2 Primers used in this study. 
 
Note: nucleotide sequences in lowercase letters represent restriction enzyme recognition sites 
 
 
  
Primer name Sequence Comment 
GAL80-f 
TCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGT
CATGAGATTGTACTGAGAGTGCAC 
GAL80 deletion cassette - forward 
GAL80-r 
TCGCTGCACTGGGGGCCAAGCACAGGGCAAGATG
CTTTTACTGTGCGGTATTTCACACCG 
GAL80 deletion cassette - reverse 
G1 CGATGTCTCTGTTTAAATGGCGCAAG GAL80 upstream (confirmation) 
G2 TTAGTTTTGCTGGCCGCATCTTCTC URA3 reverse (confirmation) 
YHP1-f 
GAAATAACAATAACACAAAATATCGTATATATATAAC
ATGAGATTGTACTGAGAGTGCAC 
YHP1 deletion cassette – forward 
YHP1-r 
TAGCATCAGTGCTCAAGAAAATAAACACTGAGAAA
GATTACTGTGCGGTATTTCACACCG 
YHP1 deletion cassette - reverse 
Y1 CCCGGAATGGTAAACATCAGACGC YHP1 upstream (confirmation) 
Y2 CCACCATTGCCTATTTGGTCCTTGG LEU2 reverse (confirmation) 
Y3 CCAAGACCACTGGTAGAAGAAGAGC YHP1 reverse (confirmation) 
mYHP1-f GCCggatccAAAACGGTAATATGAAGGAACCGTCC Cloning mutant YHP1 – forward 
mYHP1-r GCCctcgaCAGCTTGGTTCTTGAACCGTC Cloning mutant YHP1 - reverse 
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Table 3.3 List of variants common to evolved strains JQ-G1 and JQ-G2 that were not present in 
starting strain BY4742 ∆cox9. 
 
Chromosome Region Type Reference Allele 
Coding 
region 
Amino acid 
change 
Non-
synonymous 
Gene 
II 715509 SNV G A YBR248C  No  
IV 1361983 SNV C G YDR451C Glu67Gln Yes YHP1 
X 156712 SNV G A YJL136C  No  
X 531404 SNV C A   -  
XII 52619 Del T -   -  
XII 799073 SNV G C YLR335W  No  
XIII 172635 SNV G T YML051W Glu348* Yes GAL80 
XIV 6637 Del A - YNL338W His26fs Yes 
Dubious 
ORF 
XVI 260986 Ins - T   -  
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Table 3.4 Comparison of galactose fermentation parameters by S. cerevisiae strains used in this 
study. 
 
Strains YEtOH ± SD PEtOH ± SD XFinal ± SD 
BY4742 0.197 ± 0.021 1.349 ± 0.245 1.037 ± 0.006 
BY4742 ∆yhp1 0.213 ± 0.017 1.426 ± 0.168 1.011 ± 0.034 
BY4742 ∆cox9 0 0 0.03 
BY4742 ∆gal80 0.289 ± 0.000 3.143 ± 0.082 1.017 ± 0.013 
BY4742 ∆gal80∆yhp1 0.301 ± 0.003 3.227 ± 0.122 1.065 ± 0.021 
BY4742 ∆cox9∆gal80 0.389 ± 0.007 7.548 ± 0.199 0.759 ± 0.004 
BY4742 ∆cox9∆gal80∆yhp1 0.390 ± 0.014 7.457 ± 0.469 0.774 ± 0.008 
JQ-G1 0.384 ± 0.003 9.290 ± 0.153 0.830 ± 0.011 
JQ-G1-COX9 0.293 ± 0.000 4.758 ± 0.072 0.843 ± 0.025 
 
a
Fermentation parameters: YEtoh, ethanol yield (g ethanol/g galactose); PEtoh, specific ethanol productivity (g 
ethanol/g cells∙hr); XFinal, final cell density (g cells/L); SD means standard deviation 
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CHAPTER IV       INCREASING XYLOSE FERMENTATION EFFICIENCY BY 
ENGINEERED RESPIRATION-DEFICIENT SACCHAROMYCES CEREVISIAE   
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4.1  Introduction 
 Most eukaryotic organisms that naturally assimilate xylose, such as the yeast 
Scheffersomyces stipitis, make use of the xylose reductase (XR) and xylitol dehydrogenase 
(XDH) pathway.  The XR enzyme converts xylose to intermediate xylitol, which requires NADH 
or NADPH as a cofactor.  Then, XDH converts xylitol to xylulose, and this step regenerates 
NADH only (Yablochkova et al., 2003).  When the XR enzyme uses NADPH as the cofactor, the 
redox imbalance involved with xylose conversion through the pathway creates a demand for 
respiration to supply needed NAD
+
.   Therefore, many yeasts cannot ferment xylose in the 
absence of oxygen because of the redox limitation (Bruinenberg et al., 1983).  The widely used 
industrial yeast Saccharomyces cerevisiae, which is well-suited for metabolic engineering 
studies, cannot metabolize xylose but can assimilate xylulose through the pentose phosphate 
pathway.  Numerous studies have introduced the heterologous XR/XDH pathway into S. 
cerevisiae for developing recombinant xylose-fermenting strains.  Still, oxygen availability and 
respiration are generally important for ethanol production from xylose by engineered S. 
cerevisiae (Jin et al., 2004).  Evolutionary engineering has been used to generate mutant S. 
cerevisiae strains that can grow anaerobically on xylose, but the evolved strains still showed a 
fairly low ethanol yield of ≤ 0.25 g/g in these conditions and the mutations were not well 
characterized (Sonderegger and Sauer, 2003). 
 As mentioned in previous chapters, there are many advantages for engineering ethanol-
fermenting yeast strains that can function in the absence of oxygen (i.e. without respiration).  
Anaerobic conditions are desirable because they prohibit ethanol consumption and oxidative 
metabolism of sugars, both of which can significantly reduce product yield.  Also, it is more 
economical to operate industrial-scale fermentations without aeration.  Respiration-deficient 
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strains mimic an anaerobic fermentation in any environment and thus have advantages for 
industrial fermentation processes.  In this study, the objective was to engineer an efficient 
xylose-fermenting yeast strain without respiration, despite the typical challenge of NAD
+
 
shortage associated with the XR/XDH pathway in anaerobic conditions.   Improved xylose-
fermenting mutants were generated by (i) deletion of a respiratory enzyme subunit (COX9) in an 
engineered S. cerevisiae strain (SR8) expressing the XR/XDH pathway genes, and (ii) adaptive 
evolution of SR8 ∆cox9 in xylose minimal media.  Genome sequencing and a yeast mating 
experiment were combined to understand the underlying genetic basis (or bases) of the mutant 
phenotype.  
 
4.2  Materials and methods 
 
4.2.1  Strains and plasmids 
 The xylose-fermenting S. cerevisiae strain SR8 was constructed previously in our 
laboratory (Kim et al., 2013a) by (i) balanced heterologous expression of XYL1 (encoding xylose 
reductase), XYL2 (encoding xylose dehydrogenase), and XYL3 (encoding xylulokinase), (ii) 
laboratory evolution on xylose, and (iii) deletion of ALD6 (encoding acetaldehyde 
dehydrogenase).  For constructing the SR8 ∆cox9 mutant, a COX9 deletion cassette with KanMX 
marker was amplified from BY4742 ∆cox9 (Yeast Knockout MATalpha Collection, 
OpenBiosystems, Lafayette, CO) by PCR with primers COX9-f and COX9-r (Table 2.1).  The 
deletion cassette was integrated into the genome of SR8 by transformation using a high 
efficiency lithium acetate protocol (Gietz and Schiestl, 2007b) and then positive transformants 
were selected by G418 resistance on YPD agar plates. For constructing the SR8-mSPT3 and SR8 
∆cox9-mSPT3 strains, the CRISPR-Cas system (DiCarlo et al., 2013) was used to introduce a 
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frameshift mutation (Glu223fs) in SPT3 of the SR8 and SR8 ∆cox9 strains, respectively.  The 
guide RNA, which was designed to cut the genomic DNA in the SPT3 region, was cloned into 
vector pRS42H using restriction enzymes KpnI and SacI.  The 90 bp donor DNA was designed 
to leave a single nucleotide deletion (669delG) in SPT3 and also included silent mutations in the 
20-nt guide sequence to avoid repeated cutting by Cas9.  Sequences for the guide RNA, donor 
DNA, and all related primers are listed in Table 4.1.  A vector containing a Cas9-encoding gene 
and clonNAT resistance marker was transformed into the host strains (SR8 and SR8 ∆cox9) 
followed by co-transformation with the donor DNA and the guide RNA vector.  Positive 
transformants with mutant SPT3 were selected on a YPD agar plate with clonNAT and 
hygromycin.  The targeted frameshift mutation in SPT3 (Glu223fs) was confirmed by Sanger 
sequencing for engineered strains SR8-mSPT3 and SR8 ∆cox9-mSPT3; the same mutation was 
not observed in the SPT3 sequence of control strains SR8 or SR8 ∆cox9. 
 
4.2.2  Medium and culture conditions 
 To prepare yeast strains for inoculation, cells were cultivated overnight at 30°C and 300 
RPM in YPD medium (10 g/L yeast extract, 20 g/L Bacto peptone, 20 g/L glucose).  Batch 
fermentation was carried out by resuspending YPD-grown cells in 25 ml (or 10 ml) yeast 
synthetic complete (SC) medium composed of 1.7 g/L yeast nitrogen base, 5 g/L ammonium 
sulfate, and 0.79 g/L CSM (MP Biomedicals, Solon, OH) for supplying amino acids and 
nucleobases.  Xylose (or other sugar) was included in the SC media to provide the carbon source.  
Precultured cells were inoculated to fresh media at initial cell density of 0.03 g/L, unless noted 
otherwise.  Fermentation flasks were incubated at 30°C and 100 RPM in a well-controlled 
shaking incubator to maintain an oxygen-limited condition during the course of the experiment.  
At regular intervals, samples of 200 μl were taken to measure the OD600 and metabolite 
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concentrations.  For cloning, E. coli was grown overnight in Luria-Bertani medium at 37°C with 
50 μg/ml of ampicillin added when necessary.  To select yeast transformants with an antiobiotic 
resistance gene marker, YPD agar plates were used containing one or more of the following as 
appropriate: 200 μg/ml G418, 120 μg/ml clonNAT, and/or 300 μg/ml hygromycin. 
 
4.2.3  Adaptive evolution on xylose 
 The SR8 ∆cox9 mutant was the starting strain for adaptive evolution in xylose minimal 
media (SCX40).  After preculture in YPD, the mutant was able to grow in SCX with much 
slower initial xylose uptake rate as compared to SR8.  When the stationary phase was reached, 
the cells were transferred to fresh SCX media for adaptive evolution but no growth or xylose 
consumption was observed in the second subculture for an extended time period.  After 
approximately 300 hours of regular monitoring, the SR8 ∆cox9 mutant began to grow and 
consume xylose more rapidly than during the first subculture with heightened ethanol yield.  The 
culture was sampled and transferred iteratively to fresh media during the stationary phase but 
further improvements in xylose fermentation parameters were not observed over the course of 
three subsequent subcultures.  Before each serial transfer, multiple xylose-evolved mutants were 
isolated from the last fermentation flask on agar plates.  The SR8 ∆cox9 evolved mutants were 
screened and the best xylose-fermenting strains were named JQ-X1, JQ-X2, and JQ-X3. 
 
4.2.4  Genome sequencing and SNP discovery 
 The genomic DNA of SR8 ∆cox9 and evolved strains JQ-X1, JQ-X2, and JQ-X3 was 
prepared with the YeaStar Genomic DNA Kit (Zymo Research, Irvine, CA) and quality was 
confirmed in a 1% agarose gel.  Sequencing (SE100) was done using an Illumina HiSeq2000 
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machine at the W.M. Keck Center for Comparative and Functional Genomics at the University of 
Illinois at Urbana-Champaign.  The barcoded shotgun genomic DNA libraries were constructed 
with the TruSeq Sample Prep Kit following the manufacturer’s instructions (Illumina, San Diego, 
CA).  The raw data was processed with Casava 1.8, and over 15,000,000 reads were obtained for 
each sample.  Variant analysis (either SNPs or INDELs) was performed using CLC Genomics 
Workbench version 7.0.4.  Reads were trimmed based on quality scores with default program 
settings and the trimmed reads were mapped to an S288C reference sequence, as described 
previously (section 3.2.5).  The SNPs unique to evolved strains JQ-X1, JQ-X2, and JQ-X3 
relative to SR8 ∆cox9 were then determined by comparing the SNP files using the "Filter against 
Known Variants" function in CLC Genomics Workbench.  Of the variants common to the 
evolved mutants, only 2 variants resulting in an amino acid change were unique when compared 
to the parental strain (Table 4.3).   
 
4.2.5  Yeast mating and tetrad dissection 
 The haploid strains JQ-X1 (MATalpha) and SR8 (MATa) were mated by crossing on a 
YPD agar plate and incubating at 30°C for two days.  For identifying diploids from the mating 
plate, fresh cells from the intersection of the two haploid strains were collected and diluted so as 
to isolate single colonies when spread on a second YPD plate.  A halo assay test was used to 
confirm the presence of diploids from the mating experiment.  First, the halo assay involves 
spreading each of two mating type tester strains (DBY7730 or DBY7442) on a separate YPD 
plate.  Then, the potential diploids are spotted on the lawn of each tester strain, and the plates are 
incubated overnight.  For this test, the lack of a halo around a colony indicates a diploid since it 
is not mating competent with either of the two tester strains.  After identifying diploids by the 
halo test, the diploid colonies were precultured and the cells were washed with water before 
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inoculating to sporulation medium (10 g/L potassium acetate, 1 g/L yeast extract, 0.5 g/L 
glucose) for ~7 days to generate tetrads.  When tetrads were observed under a microscope, the 
cells were treated with Zymolase and β-glucuronidase to break down the ascus coat and then 
streaked on a YPD plate.  Four ascospores were separated from each tetrad using a microneedle 
and the spores were placed at least 5 mm apart on the plate.  Plates were incubated at 30°C and 
all spores were confirmed to be haploid by repeating the halo assay test.       
 
4.2.6  Analytical methods 
Cell concentration was measured by optical density (OD) at 600 nm using a UV-visible 
spectrophotometer (Biomate 3, Thermoscientific, Madison, WI).  The concentration of sugar, 
ethanol, glycerol, and acetate in batch fermentations was determined by a high-performance 
liquid chromatography system (Agilent Technologies 1200 series) with a refractive index 
detector (RID) and a Rezex ROA-Organic Acid H+ column (Phenomenex Inc., Torrance, CA).  
The column temperature was kept constant at 50°C and the elution was performed with 0.005 N 
H2SO4 at a flow rate of 0.6 ml/min.   
 
4.3  Results and discussion 
 
4.3.1  Characterization of evolved mutants 
 Despite the inherent connection between heightened respiratory activity and efficient 
xylose utilization by engineered S. cerevisiae (Jin et al., 2004), we found that an engineered 
xylose-fermenting strain with respiration deficiency (SR8 ∆cox9) was able to consume xylose 
more rapidly with a substantial improvement in ethanol yield after serial subcultures in xylose 
minimal media.  Similar to the adaptive evolution on galactose by a respiration-deficient strain 
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(Section 3.3.1), the change in xylose uptake rate and ethanol yield by SR8 ∆cox9 during the 
serial subculture was quite abrupt with little or no further improvement after the second transfer.  
During the evolution process, many xylose-evolved mutants were isolated and screened from 
each fermentation flask, and the best ethanol-producing strains were named JQ-X1, JQ-X2, and 
JQ-X3.  The evolved strains were superior to SR8 in terms of both ethanol yield (32% 
improvement) and volumetric productivity (37% improvement) during batch fermentation in 
xylose minimal media.  Fig. 4.1 shows a complete fermentation profile by SR8 (a), knockout 
SR8 ∆cox9 (b), and evolved knockout JQ-X1 (c) in minimal media with 40 g/L xylose.  One 
interesting characteristic of the evolved JQ-X1 strain is a much higher xylitol yield (0.18 ± 0.01 
g/g) than SR8 (0.01 ± 0.00 g/g), which may be related to a shortage of NAD
+
 for driving the 
xylitol dehydrogenase reaction; this is likely caused by lack of respiration in the JQ-X1 strain.  
While xylitol production is often considered to be an undesirable characteristic of xylose-
fermenting strains, we expected that the NADH surplus in the JQ-X1 strain would be useful for 
further metabolic engineering (see Chapter V).  Despite conversion of more xylose to xylitol, the 
evolved mutant still fermented ethanol faster and more efficiently than either SR8 or SR8 ∆cox9.  
When calculated on the basis of xylose assimilated, the ethanol yield by JQ-X1 (0.35 ± 0.02 g/g 
xylose assimilated) far exceeded that of the parental strain SR8 (0.22 ± 0.01 g/g xylose 
assimilated).  Table 4.2 describes some other relevant fermentation parameters for the engineered 
and evolved strains in this study.     
 
4.3.2 Changes in genotype of the evolved xylose-fermenting strains 
 The entire genome of the evolved mutants JQ-X1, JQ-X2, and JQ-X3, as well as parental 
strain SR8 ∆cox9, was sequenced and compared in order to identify genetic perturbations 
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associated with improved xylose metabolism without respiration.  Any SNP observed in the 
evolved strains but not present in the control strain may contribute to our beneficial phenotype.  
After eliminating silent substitutions or genetic mutations in non-coding regions, there were only 
two remaining SNPs shared in all evolved strains: a point mutation in MYO4 (Leu37Phe) and a 
frameshift mutation in SPT3 (Glu223fs).  MYO4 encodes a myosin motor, which is required for 
transport of mRNA and other cargo to polarized regions of the cell (Haarer et al., 1994; Pruyne 
et al., 2004).  SPT3 is known to encode a subunit of SAGA, which is a transcriptional regulatory 
complex in yeast (Grant et al., 1997).  It is noteworthy that Spt3p interacts with Spt15p for 
activating transcription, and a previous study found that three separate mutations in SPT15 
improved ethanol production from glucose and ethanol tolerance by S. cerevisiae (Alper et al., 
2006).   
 
4.3.3  Evaluation of spores from yeast mating and tetrad dissection 
 In order to study the relationship between genotype and phenotype in the evolved JQ-X1 
strain, a yeast mating experiment was conducted (Fig. 4.2a).  After mating of the evolved strain 
with parental strain SR8, diploids were isolated and inoculated into sporulation media to generate 
tetrads.  Twenty tetrads were dissected under microscope using a microneedle and plated on an 
agar plate.  The plates were incubated for 2-3 days and thirteen of the twenty tetrads grew a 
complete family of four spores.  To identify the spores in each family with or without COX9, the 
thirteen families (52 total spores) were plated on YPD with antibiotic G418.  Since COX9 was 
deleted by replacement with a kanMX marker, only the COX9-negative spores should be able to 
grow on G418.  After incubation of the plates, we found that two of the four spores in each 
family were COX9-negative and thus half of the spores in a family are respiration-deficient.  
Also, the mating type of each spore was determined by plating all 52 spores on YPD spread with 
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one of the mating type tester strains (A or alpha).  As expected, each of the thirteen families 
contained two mating type A and two mating type alpha spores (Fig. 4.2b).  The phenotype of 
three families (12 total spores) was evaluated by fermentation in xylose minimal media, and the 
ethanol yield was calculated at 102 hours (Fig. 4.2c).  The fermentation results led to two very 
interesting observations.  First, the average ethanol yield for the COX9-negative spores (0.36 ± 
0.03 g/g) was significantly higher than that for the COX9-positive spores (0.20 ± 0.04 g/g) in the 
three families tested.  Second, the two COX9-negative spores (or the two COX9-positive spores) 
within a family did not show the same phenotype but in every case one outperformed the other in 
terms of ethanol yield.  Based on the genome sequencing results for JQ-X1, we expected that a 
mutation in SPT3 and/or MYO4 (Table 4.3) may play a role in the improved fermentation 
performance by certain spores.  Although sequencing of MYO4 from the spores did not reveal 
any interesting associations, we found the SPT3 frameshift mutation (Glu223fs) in all of the 
respiration-deficient spores with better phenotype in three families.  Of the respiration-competent 
spores, two out of three with better phenotype in a family had the SPT3 mutation (Fig. 4.3).  The 
results led to the hypothesis that the SPT3 frameshift mutation was indeed an important genetic 
perturbation for improving xylose fermentation by a respiration-deficient xylose-utilizing strain. 
 
4.3.4  Effect of mutant SPT3 on SR8 and SR8 ∆cox9 phenotype 
 In order to clearly determine the effect of mutant SPT3 on xylose fermentation with or 
without respiration, we constructed the engineered strains SR8-mSPT3 and SR8 ∆cox9-mSPT3 
by using the CRISPR-Cas9 genome editing system.  After strain construction, the phenotypes 
were evaluated during flask fermentation in xylose minimal media.  For the respiration-deficient 
strains (SR8 ∆cox9 and SR8 ∆cox9-mSPT3), xylose fermentation results are shown in Fig. 4.4 
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along with results for respiration-deficient evolved strain JQ-X1.  In the COX9-negative 
background, mutant SPT3 led to a 25% improvement in xylose uptake rate and a 22% 
improvement in ethanol productivity as compared to parental strain SR8 ∆cox9.  In comparison, 
evolved strain JQ-X1 showed a similar 24% improvement in xylose uptake rate and a 31% 
improvement in ethanol productivity as compared to the parental strain (SR8 ∆cox9) in the same 
conditions.  The SR8 ∆cox9-mSPT3 strain also demonstrated a 3.9-fold increase in xylitol 
production and a 54% reduction in glycerol production as compared to SR8 ∆cox9; this result 
was similar to the 3.3-fold increase in xylitol production and 46% reduction in glycerol 
production by JQ-X1 versus the SR8 ∆cox9 strain.  In summary, the results demonstrate that the 
frameshift mutation in SPT3 (Glu223fs), which was identified by genome sequencing of evolved 
strain JQ-X1, is an important factor for improving ethanol fermentation from xylose in a 
respiration-deficient XR/XDH-expressing strain; however, this mutation is also associated with 
heightened xylitol production.  For the COX9-positive strains (SR8 and SR8-mSPT3), the mutant 
SPT3 led to a substantial decrease in xylose uptake rate, cell growth, and ethanol productivity as 
compared to the control (SR8).  The SPT3 mutation was clearly detrimental for xylose 
fermentation when respiration was able to proceed normally.   
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4.4  Figures and tables 
 
Fig. 4.1 Comparison of fermentation profiles in xylose (40 g/L) minimal media by engineered 
and evolved S. cerevisiae strains (a) SR8, (b) SR8 ∆cox9, and (c) JQ-X1 (SR8 ∆cox9 evolved).   
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Fig. 4.2 (a) Xylose-fermenting strains SR8 and JQ-X1 were mated to obtain daughter cells for 
studying genotype-phenotype relationships in the parental strains.  (b) In order to discern mating 
type and genotypic information about the daughter cells, the spores were plated on YPD plates 
with (clockwise from top left) no addition, antibiotic G418, mating type A tester, or mating type 
alpha tester.  (c) The phenotype of the spores was evaluated by fermentation in xylose minimal 
media and ethanol yield was calculated for each spore.  
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Fig. 4.2 (cont.) 
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Fig. 4.2 (cont.) 
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Fig. 4.3 For three families of spores generated by mating of SR8 and JQ-X1 followed by tetrad 
dissection, the SPT3 region was amplified by PCR and then sequenced by Sanger sequencing.  
The table organizes the spores by genotype (COX9-positive or COX9-negative) and phenotype 
(better or worse in terms of ethanol yield) and also identifies where the frameshift mutation in 
SPT3 was found (green box).  
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Fig. 4.4 Effect of mutant SPT3 in XR/XDH-expressing S. cerevisiae strains with respiration 
deficiency (SR8 ∆cox9 mSPT3 and JQ-X1) as compared to the control (SR8 ∆cox9).  
Fermentation was conducted in 25 ml of xylose minimal media under oxygen-limited conditions 
with initial cell density ~0.3 g/L (OD600=1.0).  Bars show consumed xylose (a) and production of 
ethanol, xylitol, and glycerol (b) for all strains after 23 hours of cultivation. 
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Table 4.1 Primers used in this study. 
 
Note: nucleotide sequences in lowercase letters represent restriction enzyme recognition sites; 
red letters denote the 20 nt guide sequence for Cas9 
  
Primer name Sequence Comment 
Guide RNA 
TCTACAGCGGCCGCgagctcTCTTTGAAAAGATAATGTA
TGATTATGCTTTCACTCATATTTATACAGAAACTTGAT
GTTTTCTTTCGAGTATATACAAGGTGATTACATGTAC
GTTTGAAGTACAACTCTAGATTTTGTAGTGCCCTCTT
GGGCTAGCGGTAAAGGTGCGCATTTTTTCACACCCT
ACAATGTTCTGTTCAAAAGATTTTGGTCAAACGCTG
TAGAAGTGAAAGTTGGTGCGCATGTTTCGGCGTTCG
AAACTTCTCCGCAGTGAAAGATAAATGATCGAATTT
CGCAATTAACTGAGGTTTTAGAGCTAGAAATAGCAA
GTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGAGTCGGTGGTGCTTTTTTTGTTTTTTAT
GTCTggtaccGCGGCCGCTCTATA 
Designed for cutting genomic 
DNA in the SPT3 region 
Guide-f TCTACAGCGGCCGCGAGCTCTCT Primers for amplifying guide 
RNA Guide-r TATAGAGCGGCCGCGGTACCAGA 
Donor_F 
GAATAAAAGGTTCAAGGACTGGTCTGGAATTTCGCA
ATTGACAGAGGGAAACCCCATGA 
60 bp primers with 30 bp 
homology for amplifying donor 
DNA Donor_R 
GTTAGAAACCCCAGTATATCAATCACATCATCATGGG
GTTTCCCTCTGTCAATTGCGAA 
SPT3-f TAGCGAGTGGCACTGGAAATCC Primers for Sanger sequencing 
of SPT3 SPT3-r GTCAAAGCCCTATGCCTCATGTC 
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Table 4.2 Comparison of xylose fermentation parameters by engineered and evolved S. 
cerevisiae strains in minimal media with 40 g/L xylose.  Cells were inoculated at initial cell 
density ~0.03 g/L (OD600 = 0.1). 
 
 Strains 
Fermentation parameters
a
 SR8 SR8 ∆cox9 JQ-X1 
Consumed xylose (g/L) 32.23 ± 0.49 28.18 ± 0.16 33.51 ± 0.15 
Ethanol titer (g/L) 7.04 ± 0.60 7.79 ± 0.12 9.61 ± 0.52 
YEthanol* 0.22 ± 0.01 0.32 ± 0.01 0.35 ± 0.02 
Xylitol titer (g/L) 0.19 ± 0.07 3.97 ± 0.12 6.04 ± 0.25 
YXylitol 0.01 ± 0.00 0.14 ± 0.00 0.18 ± 0.01 
Glycerol titer (g/L) 2.42 ± 0.42 3.34 ± 0.00 1.95 ± 0.04 
XFinal 1.63 ± 0.00 0.68 ± 0.02 0.75 ± 0.01 
 
a
Fermentation parameters: YEthanol*, ethanol yield (g ethanol/g xylose assimilated); YXylitol, xylitol yield (g xylitol/g 
xylose); XFinal, final cell density (g cells/L); all parameters were calculated at 167 hours 
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Table 4.3 List of variants common to evolved strains JQ-X1, JQ-X2, and JQ-X3 that cause an 
amino acid change and were not present in starting strain SR8 ∆cox9. 
 
Chromosome Region Type Reference Allele 
Coding 
region 
Amino acid 
change 
Non-
synonymous 
Gene 
I 92160 SNV G T YAL029C Leu37Phe Yes MYO4 
IV 1259364 Del G - YDR392W Glu223fs Yes SPT3 
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CHAPTER V       TWO REDOX BALANCING STRATEGIES FOR IMPROVING 
XYLOSE FERMENTATION BY ENGINEERED SACCHAROMYCES CEREVISIAE 
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5.1  Introduction 
 Redox imbalance is known to be a major challenge for efficient xylose fermentation in 
recombinant Saccharomyces cerevisiae transformed with the xylose reductase (XR) and xylitol 
dehydrogenase (XDH) genes from Scheffersomyces stipitis.  The heterologous pathway is 
generally associated with xylitol production, especially in anaerobic or microaerobic conditions, 
due to different coenzyme specificity between XR and XDH.  Still, some recent reports have 
noted advantages of the XR/XDH pathway as compared to the redox-neutral xylose isomerase 
(XI) pathway from Piromyces (Bettiga et al., 2008; Karhumaa et al., 2007).  In order to alleviate 
the redox imbalance problem and improve ethanol production from xylose by engineered S. 
cerevisiae, expression of a mutant XR with preference for cofactor NADH (rather than NADPH) 
has been demonstrated as a useful strategy.  For example, one study used protein engineering to 
generate a mutant XR with a single amino acid change (Arg276His) for improving the ratio of 
specific activity with NADH to specific activity with NADPH by 46-fold.  Expression of the 
mutant XR with a wild-type XDH gene from S. stipitis led to a 20% increase in ethanol 
production and 52% reduction in xylitol as compared to a similar strain with wild-type XR 
(Watanabe et al., 2007b).  Alternatively, expression of a mutant XDH with preference for 
cofactor NADP
+
 (rather than NAD
+
) has also been shown to be effective for improving ethanol 
production by engineered xylose-fermenting S. cerevisiae (Matsushika et al., 2008; Watanabe et 
al., 2007a).   
More recently, a rational metabolic engineering strategy led to an acetate and xylose co-
consuming S. cerevisiae strain that makes use of the NADH-producing xylose utilization 
pathway by introducing an NADH-consuming acetate reduction pathway (Wei et al., 2013).  
Acetic acid is a necessary but problematic component of cellulosic hydrolysates that results from 
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acetylation of hemicellulose and lignin in the plant cell wall (Klinke et al., 2004).  Acetate 
assimilation can enhance microbial fermentation in two specific ways: (i) by improving 
fermentation yields due to conversion of an additional carbon source, and (ii) by detoxifying the 
media through lowering the concentration of an inhibitory compound.  Native S. cerevisiae 
strains possess an acetyl coenzyme A (acetyl-CoA) synthetase for conversion of acetic acid to 
acetyl-CoA.  Expression of NADH-dependent acetylating acetaldehyde dehydrogenase (AADH), 
which is not present in wild-type S. cerevisiae, was shown to complete the acetate reduction 
pathway by bioconversion of acetyl-CoA to acetaldehyde.  Subsequently, the native alcohol 
dehydrogenase catalyzes the reduction of acetaldehyde to ethanol.  Operation of this pathway by 
engineered yeast led to a 6% increase in ethanol yield and 11% reduction in by-product yield 
during anaerobic fermentation of mixed sugars (Wei et al., 2013).  Although a recent report 
claimed superiority of the redox-neutral xylose isomerase pathway (Lee et al., 2014), the 
potential for acetate reduction due to surplus NADH generated in the XR/XDH pathway may 
offer advantages for cellulosic biofuel production.  The acetate and xylose co-consumption 
strategy has turned a significant challenge of the XR/XDH pathway into a valuable asset.   
Previously, we engineered a respiration-deficient xylose-fermenting yeast strain by 
deletion of an electron transport chain enzyme subunit and evolutionary engineering (see Chapter 
IV).  While the evolved JQ-X1 strain showed significant improvement in ethanol production as 
compared to parental strain SR8 in xylose minimal media, we also reported high xylitol yield by 
the mutant due to redox imbalance.  Excess xylitol production in the JQ-X1 strain indicates a 
shortage of NAD
+
 for driving the xylitol dehydrogenase reaction, and this is likely related to 
respiration deficiency.  Thus, we hypothesized that two aforementioned redox balancing 
strategies, namely introduction of an NADH-dependent acetate reduction pathway or 
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introduction of an NADH-preferring xylose reductase, could supply more NAD
+
 for reducing 
xylitol production and further improving ethanol production in the respiration-deficient strain.  In 
this study, a heterologous gene (adhE) encoding acetylating acetaldehyde dehydrogenase 
(AADH) was transformed into JQ-X1; the results demonstrate operation of the acetate 
assimilation pathway and improved ethanol production by the adhE-expressing strain during 
anaerobic fermentation of xylose and acetate.  Separately, the mutant S. stipitis gene encoding an 
XR with preference for cofactor NADH (Arg276His) was also transformed into the JQ-X1 strain 
on a multi-copy plasmid.  However, the results did not show improvement in ethanol production 
or reduction in xylitol by the transformants.  
 
5.2  Materials and methods 
 
5.2.1  Strains and plasmids 
 The evolved respiration-deficient S. cerevisiae strain JQ-X1 (see chapter IV) was used in 
this study for expressing mutant xylose reductase and the acetate reduction pathway.  To 
introduce an acetylating acetaldehyde dehydrogenase (AADH) into the JQ-X1 strain, we used an 
E. coli adhE (NCBI Gene ID: 945837) that was codon-optimized for S. cerevisiae.  The codon-
optimized adhE was cloned into integration plasmid pITy3 with PGK promoter and terminator; 
the gene for resistance to antibiotic hygromycin was also cloned into the plasmid.  After cutting 
with restriction enzyme XhoI to linearize, the pITy3-co-adhE plasmid was then transformed into 
JQ-X1 by a high efficiency lithium acetate procedure (Gietz and Schiestl, 2007a) for integration 
at the delta sequences.  Positive transformants were selected on a YPD agar plate with 
hygromycin and colony PCR was used to confirm the presence of adhE.  To increase enzymatic 
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activity in the JQ-X1-adhE strain, the CRISPR-Cas system (DiCarlo et al., 2013) was used to 
introduce another copy of codon-optimized adhE, resulting in strain JQ-X1-adhE-adhE.  The 
guide RNA, which was designed to cut the genomic DNA in the PHO13 region, was cloned into 
Blasticidin resistance vector OG539 (Oxford Genetics) using restriction enzymes KpnI and SacI.  
A vector containing clonNAT resistance marker and Cas9-encoding gene was transformed into 
the host strain (JQ-X1-adhE) first followed by co-transformation with donor DNA and the guide 
RNA vector.  Positive transformants were selected on a YPD agar plate containing clonNAT and 
blasticidin and then colony PCR was used to confirm the presence of adhE in the PHO13 region.     
 For expressing an NADH-preferring xylose reductase in the JQ-X1 strain, a mutant S. 
stipitis XYL1 (Arg276His) was cloned into vector pRS42H with GPD promoter and CYC 
terminator.  The pRS42H-mutXR plasmid was transformed into JQ-X1 by a high-efficiency 
lithium acetate procedure and positive transformants were selected on a YPD agar plate with 
hygromycin.   
 
5.2.2 Medium and culture conditions 
 To prepare yeast strains for inoculation, cells were cultivated overnight at 30°C and 300 
RPM in YPD medium (10 g/L yeast extract, 20 g/L Bacto peptone, 20 g/L glucose).  Batch 
fermentation was carried out by resuspending YPD-grown cells in yeast synthetic complete (SC) 
medium composed of 1.7 g/L yeast nitrogen base, 5 g/L ammonium sulfate, and 0.79 g/L CSM 
(MP Biomedicals, Solon, OH) for supplying amino acids and nucleobases.  Xylose was included 
in the SC media to provide the carbon source (SCX), and 3 M sodium acetate was also added to 
the appropriate concentration for xylose/acetate co-consumption experiments (SCXA).  
Precultured cells were harvested in exponential phase and inoculated to fresh media after 
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removing used YPD.  Fermentation flasks were incubated at 30°C and 100 RPM in a well-
controlled shaking incubator (Thermoscientific, MaxQ4000, Dubuque, IA) during the course of 
the experiment.  At regular intervals, samples of 200 μl were taken to measure the OD600 and 
metabolite concentrations.  For anaerobic fermentations, ergosterol and Tween80 were included 
in SCXA medium at a final concentration of 10 mg/L and 420 mg/L, respectively.  Anaerobic 
fermentations were conducted in 20 mL of SCXA (or YPXA) media in a sealed and nitrogen-
purged 100 mL vial.  To select yeast transformants with an antiobiotic resistance gene marker, 
YPD agar plates were used containing one or more of the following as appropriate: 300 μg/ml 
hygromycin, 120 μg/ml clonNAT, and/or 100 μg/ml blasticidin.  For cloning, E. coli was grown 
overnight in Luria-Bertani medium at 37°C with 50 μg/ml of ampicillin added when necessary.   
 
5.2.3  Enzymatic activity assays 
 For measuring activity of AADH in engineered yeast strains, cell extracts were obtained 
from anaerobic xylose fermentation during exponential phase growth.  Cells were washed with a 
cocktail of 1 mM dithiothreitol and protease inhibitor tablet (Roche, catalog #04693116001) and 
then vortexed with sterile glass beads for 10 min to break the cell walls and release cellular 
contents.  The enzymatic reaction was conducted in a 96-well plate (total volume = 200 μL) by 
adding 24 μL of acetyl conenzyme A (10.29 mM), 20 μL of NADH (2.82 mM), and 5 μL of 
protein extract into 151 μL of potassium phosphate buffer (50 mM, pH 7.5).  Enzymatic activity 
was evaluated in triplicates using a microplate reader (BioTek, Winooski, VT) by monitoring 
NADH oxidation as measured from the change in absorbance at 340 nm.  The AADH activity 
was normalized by total protein concentration in the extract as determined from a Pierce BCA 
Protein Assay Kit (Thermo Scientific).   
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 To measure XR activity in engineered yeast strains, cell extracts were obtained during the 
exponential phase of aerobic growth in glucose media (YPD).  The media was separated by 
centrifugation and the cells were resuspended in Y-PER solution (Pierce, Rockford, IL) for 20 
min at room temperature to break the cell walls and release cellular contents.  After a 10 min 
centrifugation at 4°C, the crude enzyme extract (supernatant) was obtained and stored on ice.  
The enzymatic reaction was conducted in a 96-well plate (total volume = 200 μL) by adding 20 
μl of xylose (1 M), 20 μl of NADH or NADPH (2 mM), and 20 μl of protein extract into 140 μl 
of sodium phosphate buffer (50 mM, pH 6.5).  Enzymatic activity was evaluated in triplicates 
using a microplate reader (BioTek, Winooski, VT) by monitoring NADH (or NADPH) oxidation 
as measured from the change in absorbance at 340 nm.  The XR activity was normalized by total 
protein concentration in the extract as determined from a Pierce BCA Protein Assay Kit (Thermo 
Scientific).   
 
5.2.4  Analytical methods 
Cell concentration was measured by optical density (OD) at 600 nm using a UV-visible 
spectrophotometer (Biomate 3, Thermoscientific, Madison, WI).  The concentration of sugar, 
ethanol, glycerol, and acetate in batch fermentations was determined by a high-performance 
liquid chromatography system (Agilent Technologies 1200 series) with a refractive index 
detector (RID) and a Rezex ROA-Organic Acid H+ column (Phenomenex Inc., Torrance, CA).  
The column temperature was kept constant at 50°C and the elution was performed with 0.005 N 
H2SO4 at a flow rate of 0.6 ml/min.   
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5.3  Results and discussion 
 
5.3.1 Expression of acetate reduction pathway in JQ-X1 strain 
 In order to create a demand for surplus NADH generated by the XR/XDH pathway, we 
introduced a heterologous gene (adhE) encoding NADH-consuming acetylating acetaldehyde 
dehydrogenase (AADH) to evolved strain JQ-X1 and thus completed the acetate reduction 
pathway in the resulting JQ-X1-ahdE strain.  Due to balancing of redox cofactors and 
assimilation of a second carbon source, we expected that co-fermentation of xylose and acetate 
by the adhE-expressing strain would show reduced xylitol production and improved ethanol 
production as compared to parental strain JQ-X1.   To test the hypothesis, the JQ-X1-adhE strain 
was evaluated during anaerobic fermentation of xylose and acetate in various conditions.  In 
complex media with 2 g/L of acetate and 40 g/L of xylose, JQ-X1-adhE was able to consume 
1.39 g/L of acetate in the 222 hours required to deplete greater than 90% of initial xylose (Fig. 
5.1b).  The control JQ-X1 did not consume acetate and used xylose at a 5.5% lower rate than JQ-
X1-adhE (Fig. 5.1a).   The relatively slow xylose utilization rate by the engineered strains was 
due to low initial cell density (~0.03 g/L) in this experiment.  Still, we were able to validate our 
hypothesis since the adhE-expressing strain showed a 15% improvement in ethanol yield and 
55% reduction in xylitol yield as compared to the non-acetate consuming strain.  To improve 
sugar uptake rate and fermentation rate, we conducted a similar experiment in complex media 
(YPXA) with a ten-fold higher initial cell density of 0.3 g/L (Fig. 5.2).  With the addition of 
more cells, JQ-X1-adhE showed a 3.3-fold improvement in xylose uptake rate as compared to 
the same strain in the low cell density experiment and also consumed 1.15 g/L acetate in 67 
hours (Fig. 5.2b).  As expected, JQ-X1 was still unable to consume acetate in the higher cell 
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density experiment (Fig. 5.2a).  The acetate-consuming strain produced 49% more ethanol and 
had a 27% lower xylitol yield versus the control, although final xylitol titer was similar in the 
two strains.  Table 5.1 shows the key fermentation parameters by JQ-X1-adhE and the control 
during the xylose/acetate co-fermentation experiment.  In minimal media with xylose and 
acetate, the engineered S. cerevisiae strains JQ-X1 and JQ-X1-adhE were able to grow 
anaerobically but only with a lower initial acetate concentration (~1 g/L) and addition of 50 mM 
sodium phthalate buffer.  In this condition, JQ-X1-adhE consumed all acetate in 78 hours and 
demonstrated 15% higher ethanol yield than the control with a 20% lower xylitol yield.  Clearly, 
the results indicate that the NADH-consuming acetate reduction pathway can restore redox 
balance and improve ethanol production in a respiration-deficient xylose-fermenting yeast strain. 
To increase activity of AADH, the CRISPR/Cas system was used to introduce another 
copy of adhE into the JQ-X1-adhE strain.  Colony PCR confirmed success of the transformation 
and an enzymatic activity assay showed a significant 38% increase in AADH activity by JQ-X1-
adhE-adhE as compared to JQ-X1-adhE (Fig. 5.3).  However, the transformants with an 
additional adhE copy used acetate more slowly than the original JQ-X1-adhE strain and also had 
lower xylose uptake rate.  Metabolic burden and/or some detrimental mutation(s) during 
transformation may play a role in the unexpected phenotype of the JQ-X1-adhE-adhE strain.       
 
5.3.2   Expression of NADH-preferring xylose reductase in JQ-X1 strain 
 To alleviate the redox imbalance problem in strain JQ-X1, we also attempted another 
strategy that involved expression of a mutant XR previously shown to have a preference for 
cofactor NADH (rather than the NADPH preference of the wild-type XR).  Twelve 
transformants bearing mutant XR on multi-copy plasmid were selected and screened in xylose 
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minimal media (SCX).  The calculated ethanol yield and xylitol yield for all transformants and 
the control strain (JQ-X1) is shown in Fig. 5.4.  Contrary to our hypothesis, the strains with 
mutant XR had lower ethanol yield in this condition and 11 of 12 also had higher xylitol yield 
than the control strain.  However, in complex media with xylose as the sole carbon source, the 
strains expressing mutant XR showed more promising results (Fig. 5.5).  The main changes in 
this experiment were use of complex media (YPX), comparison against a proper control strain 
with empty vector (JQ-X1-pRS42H), and addition of hygromycin to all fermentation media to 
prevent plasmid loss.  In this condition, the results show a 44% improvement in ethanol 
production and a 22% reduction in xylitol production for the JQ-X1-mXR strain as compared to 
the control (JQ-X1-pRS42H).  Also, the mutant XR strain consumed xylose faster (16% 
improvement) and generated more biomass (23% improvement) than the control.  A xylose 
reductase enzymatic activity assay confirmed that expression of the mutant XR significantly 
increased the ratio of NADH-specific activity to NADPH-specific activity in the engineered 
xylose-fermenting strains (Fig. 5.6).  We hypothesize that higher NADH-specific XR activity is 
the major cause of improved xylose utilization and ethanol production by the JQ-X1-mXR strain.              
 
5.4  Figures and tables 
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Fig. 5.1 Comparison of xylose/acetate fermentation profiles by engineered S. cerevisiae strains 
(a) JQ-X1 and (b) JQ-X1-adhE with low initial cell density (OD600 = 0.1). 
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Fig. 5.2 Comparison of xylose/acetate fermentation profiles by engineered S. cerevisiae strains 
(a) JQ-X1 and (b) JQ-X1-adhE with high initial cell density (OD600 = 1.0).  All results are the 
average of duplicate experiments. The error bars represent one standard deviation and are not 
visible when smaller than the symbol size. 
  
 126 
 
 
 
Fig. 5.3 Enzymatic activity assay of acetylating acetaldehyde dehydrogenase reaction in two 
engineered yeast strains during acetate assimilation as compared with control strain JQ-X1.  
Results are the average of triplicate assays and error bars indicate standard deviation.  The 
student t test was used to establish significant differences between the adhE-expressing strains 
and the control. *, P < 0.05 (95% confidence) 
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Fig. 5.4 Calculated ethanol yield and xylitol yield during fermentation in xylose minimal media 
by twelve transformants harboring a vector with mutant NADH-preferring xylose reductase (red 
diamonds) as compared to control strain JQ-X1 (blue square).  
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Fig. 5.5 Xylose fermentation profiles by the JQ-X1 strain harboring either empty vector pRS42H 
(a) or the same vector with a mutant NADH-preferring xylose reductase (b).  Flask fermentations 
were conducted in complex media with 40 g/L of xylose at initial cell density ~0.15 g/L (OD600 = 
0.5).  All results are the average of duplicate experiments and the error bars represent standard 
deviation. 
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Fig. 5.6 Ratio of NADH-specific xylose reductase activity to NADPH-specific xylose reductase 
activity in JQ-X1 strains harboring either empty vector pRS42H (p1 and p2) or the same vector 
with a mutant NADH-preferring xylose reductase (mXR1 and mXR2).  Results are the average 
of triplicate assays and error bars indicate standard deviation.  The student t test was used to 
establish significant differences between the mutant XR strains and the controls. *, P < 0.05 
(95% confidence) 
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Table 5.1 Comparison of fermentation parameters by JQ-X1 and JQ-X1-adhE strains in YP 
media with 40 g/L xylose and 2 g/L acetate.  Cells were inoculated at initial cell density ~0.3 g/L 
(OD600 = 1). 
 
 Strains 
Fermentation parameters
a
 JQ-X1 JQ-X1-adhE 
Consumed xylose (g/L) 28.24 ± 0.23 37.06 ± 0.14 
Consumed acetate (g/L) 0.07 ± 0.00 1.15 ± 0.03 
Ethanol titer (g/L) 9.39 ± 0.10 14.02 ± 0.09 
YEthanol* 0.371 ± 0.00  0.409 ± 0.00  
Xylitol titer (g/L) 2.93 ± 0.02 2.80 ± 0.01 
YXylitol 0.10 ± 0.00  0.08 ± 0.00  
Glycerol titer (g/L) 1.50 ± 0.04  0.97 ± 0.02  
XFinal 1.08 ± 0.01  1.82 ± 0.03  
 
a
Fermentation parameters: YEthanol*, ethanol yield (g ethanol/g xylose assimilated); YXylitol, xylitol yield (g xylitol/g 
xylose); XFinal, final cell density (g cells/L); all parameters were calculated at 66.5 hours 
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CHAPTER VI       SUMMARY AND FUTURE STUDIES 
  
 132 
 
6.1  Summary 
 Systematic and combinatorial methods were studied and applied for uncovering genetic 
targets in yeast to improve cellular phenotype.  Specifically, perturbations were identified for 
rapid utilization of various sugars in renewable biomass and efficient conversion to fermentation 
products with high yield and productivity.  Throughout the four research chapters in the thesis, 
strain improvement was driven by metabolic engineering concepts and methodologies, such as 
flux balance analysis, evolutionary engineering, rational strain design, and inverse metabolic 
engineering.  Furthermore, systems biology approaches involving collection of genomic, 
fluxomic, and metabolomic data were applied to characterize engineered strains and accumulate 
valuable understanding about improved phenotypes at both systems and molecular levels.  The 
most important findings from each chapter are summarized below. 
     First, I performed an in silico gene deletion experiment based on a genome-scale 
metabolic model in order to determine beneficial deletions for ethanol production by S. 
cerevisiae. Genes coding for two oxidative phosphorylation reactions (cytochrome c oxidase and 
ubiquinol cytochrome c reductase) were identified by the model-based simulation as potential 
deletion targets for enhancing ethanol production and maintaining acceptable overall growth rate 
in oxygen-limited conditions. Since the two target enzymes are composed of multiple subunits, 
we conducted a genetic screening study to evaluate the in silico results and compare the effect of 
deleting various portions of the respiratory enzyme complexes. Over two-thirds of the knockout 
mutants identified by the in silico study did exhibit experimental behavior in qualitative 
agreement with model predictions, but the exceptions illustrate the limitation of using a purely 
stoichiometric model-based approach. Furthermore, there was a substantial quantitative variation 
in phenotype among the various respiration-deficient mutants that were screened in this study, 
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and three genes encoding respiratory enzyme subunits were identified as the best knockout 
targets for improving hexose fermentation in microaerobic conditions. Specifically, deletion of 
either COX9 or QCR9 resulted in higher ethanol production rates than the parental strain by 37% 
and 27%, respectively, with slight growth disadvantages. Also, deletion of QCR6 led to improved 
ethanol production rate by 24% with no growth disadvantage. The beneficial effects of these 
gene deletions were consistently demonstrated in different strain backgrounds and with four 
common hexoses. The combination of stoichiometric modeling and genetic screening using a 
systematic knockout collection was useful for narrowing a large set of gene targets and 
identifying targets of interest.  
Next, I found that deletion of respiratory enzyme subunit Cox9p, which was identified by 
the previous model-based approach, led to severe inhibition of galactose fermentation.  However, 
the metabolic “death valley” (i.e. no growth on galactose) was a necessary intermediate 
phenotype for the respiration-deficient yeast to reach optimal galactose fermentation rapidly 
through serial subcultures in galactose media.  The resulting strain JQ-G1 was able to produce 
ethanol with a 94% increase in yield and 6.9-fold improvement in specific productivity as 
compared to the wild-type strain.  
13
C-metabolic flux analysis demonstrated a three-fold 
reduction in carbon flux through the TCA cycle of the evolved mutant with redirection of flux 
toward the fermentation pathway.  Also, the intracellular concentration of galactitol and most 
TCA cycle intermediates was significantly reduced in JQ-G1 while pyruvate concentration was 
elevated as compared to the wild-type strain.  For understanding the genetic basis of the evolved 
phenotype, genome sequencing was conducted and used to identify a loss of function mutation in 
a master negative regulator of the Leloir pathway (Gal80p); this mutation was found to act 
synergistically with inhibition of respiration for efficient galactose fermentation.  Thus, deletion 
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of GAL80 alone was sufficient for rapid galactose utilization (1.30 g/L∙h) with high ethanol yield 
(0.383 g/g) in strict anaerobic conditions.  This is especially interesting since galactose 
metabolism in S. cerevisiae typically requires most or all cellular energy production by 
respiration; therefore, the wild-type yeast cannot metabolize galactose under strict anaerobic 
conditions.  The results in this section demonstrate a promising approach for directing adaptive 
evolution toward fermentative metabolism and for generating evolved yeast strains with 
improved phenotypes under anaerobic conditions. 
Finally, I applied a similar ‘fermentative evolution’ approach for improving xylose 
fermentation in an engineered strain (SR8) expressing the heterologous XR/XDH pathway.  The 
strategy involved deletion of COX9 and evolutionary engineering in xylose minimal media.  The 
resulting evolved strain JQ-X1 showed a substantial 32% improvement in ethanol yield and 37% 
improvement in ethanol productivity as compared to SR8 in xylose media.  Genome sequencing 
identified two mutations that were common to all isolated evolved mutants and also not found in 
the reference strain.  Yeast mating and tetrad dissection focused the search on one of the two 
mutations – a frameshift deletion in SPT3 (encoding a subunit of the transcriptional regulatory 
complex SAGA) which was discovered in all respiration-deficient spores with better phenotype 
on xylose.  One apparent disadvantage of JQ-X1 was a significantly higher xylitol yield (0.18 
g/g) as compared with the parental strain (0.01 g/g) due to imbalance of redox cofactors without 
sufficient respiration to replenish NAD
+
.  Expression of an NADH-consuming acetate reduction 
pathway was effective for restoring redox balance and improving ethanol production in the 
respiration-deficient xylose-fermenting yeast strain.  The acetate-consuming strain JQ-X1-adhE 
produced 49% more ethanol and had a 27% lower xylitol yield in xylose/acetate-containing 
media as compared to JQ-X1.  Also, expression of a mutant NADH-preferring xylose reductase 
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was promising for restoring redox balance and improving fermentation parameters by the 
evolved JQ-X1 strain.  The engineered JQ-X1-mXR strain produced 44% more ethanol with a 
22% reduction in xylitol as compared to the control (JQ-X1-pRS42H) during fermentation in 
xylose media. 
 
6.2  Future research directions 
 In chapter III, I noted that deletion of GAL80 permits galactose fermentation in strict 
anaerobic conditions, which was not possible in wild-type laboratory strain BY4742.  More 
experiments are needed to confirm whether this is a strain-specific effect or it can be generalized 
to all S. cerevisiae strains.  I propose to delete GAL80 in several other strain backgrounds, such 
as CEN.PK and D452-2, and then evaluate the phenotype of the knockouts and control strains in 
a sealed and purged anaerobic vial with 20 mL of minimal media and 40 g/L galactose.   
 In chapter IV, I found that a mutation in SPT3 seemed to contribute to the improved 
phenotype of xylose-fermenting strain JQ-X1.  To confirm this, I introduced the mutation into 
the SR8 and SR8 ∆cox9 strains using the CRISPR/Cas system to evaluate the effect in xylose.  
More work is needed to evaluate the effect of the frameshift mutation in SPT3 in various strains 
and during growth on various sugars.  I propose to introduce the mutation into strains BY4742 
and BY4742 ∆cox9 using the same donor DNA and guide RNA designed by me.  Using these 
strains, the effect of the mutation can be evaluated in a respiration-deficient or respiration-
sufficient laboratory strain during growth on glucose, galactose, or other sugars.   
 In chapter V, I introduced another copy of adhE to the JQ-X1-adhE strain in order to 
increase capacity for acetate assimilation.  However, all transformants showed a reduction in 
acetate consumption after introducing the extra adhE copy in the PHO13 region as described 
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previously.  I propose to clone a different, unused antibiotic resistance marker (e.g. clonNAT 
marker) into the pITy3-co-adhE integration plasmid in place of the used hygromycin marker.  
Then, the plasmid can be linearized and transformed to strain JQ-X1-adhE for inserting 
additional copies of adhE at the delta sequences.  This is a simpler alternate method to increase 
AADH activity in the xylose/acetate co-consuming strain (JQ-X1-adhE) for further improving 
redox balance and ethanol fermentation.  The resulting transformants should be tested in YPXA 
under anaerobic conditions to evaluate the phenotype.  
 In chapter V, a mutant NADH-preferring xylose reductase was transformed into JQ-X1 
on a multi-copy plasmid.  In complex media with 40 g/L of xylose, the transformants did show 
higher ethanol production and lower xylitol production as compared to the control strain with 
empty vector pRS42H.  In order to increase stability and expression of this NADH-preferring 
xylose reductase, I propose to engineer a mutant XR construct for integration into the genome of 
JQ-X1.  The mutant XR can be cloned into the pITy3 plasmid with a strong promoter and then 
the plasmid can be digested with XhoI and transformed to JQ-X1.  The resulting transformants 
should be tested in YPX and SCX to evaluate the phenotype.  
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